zeno@Mac oncobot-v3 % pnpm dev

> oncobot@0.1.0 dev /Users/zeno/Projects/oncobot-v3
> next dev --turbopack

   ‚ñ≤ Next.js 15.4.2 (Turbopack)
   - Local:        http://localhost:3000
   - Network:      http://192.168.1.166:3000
   - Environments: .env
   - Experiments (use with caution):
     ‚úì useCache
     ¬∑ staleTimes
     ¬∑ serverActions
     ¬∑ ...

 ‚úì Starting...
 ‚úì Compiled middleware in 87ms
 ‚úì Ready in 834ms
Pathname:  /
 ‚óã Compiling / ...
 ‚úì Compiled / in 6.9s
[Feature Toggle] Environment variable NEXT_PUBLIC_ENABLED_SEARCH_MODES: health
[Feature Toggle] Parsed modes: [ 'health' ]
[Feature Toggle] Mode web is disabled
[Feature Toggle] Mode memory is disabled
[Feature Toggle] Mode analysis is disabled
[Feature Toggle] Mode crypto is disabled
[Feature Toggle] Mode chat is disabled
[Feature Toggle] Mode x is disabled
[Feature Toggle] Mode reddit is disabled
[Feature Toggle] Mode academic is disabled
[Feature Toggle] Mode youtube is disabled
[Feature Toggle] Mode extreme is disabled
[Feature Toggle] Mode health is enabled
[Feature Toggle] Mode extreme is disabled
 GET / 200 in 7828ms
Pathname:  /
Pathname:  /api/auth/get-session
DB Query: 
      select b.oid, b.typarray
      from pg_catalog.pg_type a
      left join pg_catalog.pg_type b
DB Query: select "id", "expires_at", "token", "created_at", "updated_at", "ip_address", "user_agent", "user_id
DB Query: select "id", "name", "email", "email_verified", "image", "created_at", "updated_at" from "user" wher
 POST / 200 in 453ms
Pathname:  /
DB Query: select "id", "userId", "title", "created_at", "updated_at", "visibility" from "chat" where "chat"."u
 ‚óã Compiling /api/auth/[...all] ...
 POST / 200 in 103ms
Pathname:  /
DB Query: select "userHealthProfile"."id", "userHealthProfile"."user_id", "userHealthProfile"."health_profile_
 POST / 200 in 128ms
 GET /manifest.webmanifest 200 in 874ms
 GET /apple-icon.png 200 in 384ms
 ‚úì Compiled /api/auth/[...all] in 1692ms
Pathname:  /api/search
DB Query: 
      select b.oid, b.typarray
      from pg_catalog.pg_type a
      left join pg_catalog.pg_type b
DB Query: select "id", "expires_at", "token", "created_at", "updated_at", "ip_address", "user_agent", "user_id
DB Query: select "id", "name", "email", "email_verified", "image", "created_at", "updated_at" from "user" wher
 GET /api/auth/get-session 200 in 2699ms
 ‚óã Compiling /api/search ...
 ‚úì Compiled /api/search in 1353ms
üîç Search API endpoint hit
--------------------------------
Location:  undefined undefined
--------------------------------
--------------------------------
Messages:  [
  {
    id: 'Gsr4KsddTI4XiayL',
    createdAt: '2025-08-05T22:06:08.034Z',
    role: 'user',
    content: 'Are there any trials for my type and stage of cancer?',
    parts: [ [Object] ]
  }
]
--------------------------------
DB Query: select "id", "expires_at", "token", "created_at", "updated_at", "ip_address", "user_agent", "user_id
DB Query: select "id", "name", "email", "email_verified", "image", "created_at", "updated_at" from "user" wher
‚è±Ô∏è  User check took: 0.12s
DB Query: select "id", "user_id", "content", "created_at", "updated_at" from "custom_instructions" where "cust
‚è±Ô∏è  Critical checks wait took: 0.00s
[Feature Toggle] Environment variable NEXT_PUBLIC_ENABLED_SEARCH_MODES: health
[Feature Toggle] Parsed modes: [ 'health' ]
[Feature Toggle] Mode health is enabled
‚è±Ô∏è  Config loading took: 0.01s
‚è±Ô∏è  Config wait took: 0.00s
DB Query: select "id", "userId", "title", "created_at", "updated_at", "visibility" from "chat" where "chat"."i
‚è±Ô∏è  Chat check took: 0.06s
DB Query: insert into "chat" ("id", "userId", "title", "created_at", "updated_at", "visibility") values ($1, $
‚è±Ô∏è  Chat creation took: 0.07s
--------------------------------
Messages:  [
  {
    id: 'Gsr4KsddTI4XiayL',
    createdAt: '2025-08-05T22:06:08.034Z',
    role: 'user',
    content: 'Are there any trials for my type and stage of cancer?',
    parts: [ [Object] ]
  }
]
--------------------------------
Running with model:  oncobot-default
Group:  health
Timezone:  America/Chicago
Context optimization skipped (disabled or too few messages)
--------------------------------
Time to reach streamText: 0.33 seconds
--------------------------------
DB Query: insert into "message" ("id", "chat_id", "role", "parts", "attachments", "created_at") values ($1, $2
DB Query: 
      select b.oid, b.typarray
      from pg_catalog.pg_type a
      left join pg_catalog.pg_type b
DB Query: insert into "stream" ("id", "chatId", "createdAt") values ($1, $2, $3)
‚è±Ô∏è  Background operations took: 0.33s
--------------------------------
Messages saved:  [
  {
    id: 'Gsr4KsddTI4XiayL',
    createdAt: '2025-08-05T22:06:08.034Z',
    role: 'user',
    content: 'Are there any trials for my type and stage of cancer?',
    parts: [ [Object] ]
  }
]
--------------------------------
Pathname:  /search/2cf55642-fd17-41fe-871c-ee84caaccc37
 ‚óã Compiling /search/[id] ...
 ‚úì Compiled /search/[id] in 1716ms
DB Query: select "id", "userId", "title", "created_at", "updated_at", "visibility" from "chat" where "chat"."u
 POST /search/2cf55642-fd17-41fe-871c-ee84caaccc37 200 in 2286ms
Called Tool:  clinical_trials
DB Query: select "userHealthProfile"."id", "userHealthProfile"."user_id", "userHealthProfile"."health_profile_
DB Query: select "id", "health_profile_id", "question_id", "response", "created_at" from "health_profile_respo
Clinical Trials API URL: https://clinicaltrials.gov/api/v2/studies?pageSize=10&countTotal=true&sort=StartDate%3Adesc&query.cond=lung+cancer+nsclc&filter.overallStatus=RECRUITING%2CENROLLING_BY_INVITATION%2CACTIVE_NOT_RECRUITING%2CNOT_YET_RECRUITING
Condition query: lung cancer nsclc
Other terms: undefined
Intervention: undefined
Health Profile Data: {
  cancerRegion: 'THORACIC',
  cancerType: 'NSCLC',
  diseaseStage: 'MISSING',
  searchCriteria: {
    condition: 'lung cancer OR thoracic cancer OR chest cancer',
    cancerType: 'NSCLC',
    molecularMarkers: [ 'KRAS_G12C' ]
  }
}
Executing Query 1: Broad search
Executing Query 2: Molecular marker specific search
Molecular marker query: lung cancer nsclc KRAS G12C
Executing Query 3: Drug-based search
Drug query: sotorasib OR adagrasib
Multi-query results: 27 unique trials from 3 queries
  - broad_search: 10 trials
  - molecular_specific: 10 trials
  - drug_based: 10 trials
Search returned 2331 trials - this may be too broad
Trial NCT03514329: Found 0 matching markers from 1 total
Trial NCT06502249: Found 0 matching markers from 1 total
Trial NCT06772363: Found 0 matching markers from 1 total
Trial NCT06775002: Found 0 matching markers from 1 total
Trial NCT06732401: Found 0 matching markers from 1 total
Trial NCT05909137: Found 0 matching markers from 1 total
Trial NCT05764928: Found 0 matching markers from 1 total
Trial NCT06982222: Found 0 matching markers from 1 total
Trial NCT05275374: Found 0 matching markers from 1 total
Trial NCT04266730: Found 0 matching markers from 1 total
Trial NCT06793215: Found 1 matching markers from 1 total
  Matched markers: KRAS_G12C
Trial NCT07012031: Found 1 matching markers from 1 total
  Matched markers: KRAS_G12C
Trial NCT07094204: Found 1 matching markers from 1 total
  Matched markers: KRAS_G12C
Trial NCT06946927: Found 1 matching markers from 1 total
  Matched markers: KRAS_G12C
Trial NCT06936644: Found 1 matching markers from 1 total
  Matched markers: KRAS_G12C
Trial NCT06875310: Found 1 matching markers from 1 total
  Matched markers: KRAS_G12C
Trial NCT06917079: Found 1 matching markers from 1 total
  Matched markers: KRAS_G12C
Trial NCT06890598: Found 1 matching markers from 1 total
  Matched markers: KRAS_G12C
Trial NCT06594874: Found 1 matching markers from 1 total
  Matched markers: KRAS_G12C
Trial NCT06497556: Found 1 matching markers from 1 total
  Matched markers: KRAS_G12C
Trial NCT06764771: Found 1 matching markers from 1 total
  Matched markers: KRAS_G12C
Trial NCT06333951: Found 1 matching markers from 1 total
  Matched markers: KRAS_G12C
Trial NCT06582771: Found 1 matching markers from 1 total
  Matched markers: KRAS_G12C
Trial NCT06248606: Found 1 matching markers from 1 total
  Matched markers: KRAS_G12C
Trial NCT06532149: Found 0 matching markers from 1 total
Trial NCT06249282: Found 1 matching markers from 1 total
  Matched markers: KRAS_G12C
Trial NCT06333678: Found 1 matching markers from 1 total
  Matched markers: KRAS_G12C
Warnings:  []
Warnings:  []
Fin reason:  stop
Reasoning:  First, the user asked: "Are there any trials for my type and stage of cancer?" I used the clinical_trials tool to search based on their profile. The results show several trials, many relevant to NSCLC with KRAS G12C mutation, which matches the user's profile.

From the tool's response, I see that the user's profile likely includes NSCLC with KRAS G12C mutation, as many trials highlight this. I need to acknowledge the specific information from their profile.

Key points from the results:
- Total trials: 2331, but we're showing the top 15 matches.
- Many trials are for advanced NSCLC with KRAS G12C mutation, which aligns with the user's query.
- I must highlight trials that target the user's mutations, like KRAS G12C.

Structure my response:
- Start with a warm, supportive summary.
- Acknowledge the profile: "Based on your NSCLC diagnosis with KRAS G12C mutation..."
- Summarize the results: "I found 15 trials that might be relevant..."
- Present key details: Group by relevance, mention why they match (e.g., cancer type, stage, mutation).
- Highlight KRAS G12C targeted trials.
- If stage is missing, note it, but from the matches, it seems to assume advanced stages.
- End with a disclaimer and offer next steps.

Conversational flow:
- Reference the conversation: This is a follow-up to their initial query.
- Offer to discuss specifics or refine the search.
- Include the disclaimer: "This information is for educational purposes. Please consult your healthcare provider..."

Finally, keep it clear and not verbose.

Response Outline:
1. Introduction: Empathize and summarize.
2. Acknowledge profile and results.
3. Present trials: Summarize top ones, highlight matches.
4. Suggest next steps.
5. Disclaimer.
reasoning details:  [
  {
    type: 'text',
    text: `First, the user asked: "Are there any trials for my type and stage of cancer?" I used the clinical_trials tool to search based on their profile. The results show several trials, many relevant to NSCLC with KRAS G12C mutation, which matches the user's profile.\n` +
      '\n' +
      "From the tool's response, I see that the user's profile likely includes NSCLC with KRAS G12C mutation, as many trials highlight this. I need to acknowledge the specific information from their profile.\n" +
      '\n' +
      'Key points from the results:\n' +
      "- Total trials: 2331, but we're showing the top 15 matches.\n" +
      "- Many trials are for advanced NSCLC with KRAS G12C mutation, which aligns with the user's query.\n" +
      "- I must highlight trials that target the user's mutations, like KRAS G12C.\n" +
      '\n' +
      'Structure my response:\n' +
      '- Start with a warm, supportive summary.\n' +
      '- Acknowledge the profile: "Based on your NSCLC diagnosis with KRAS G12C mutation..."\n' +
      '- Summarize the results: "I found 15 trials that might be relevant..."\n' +
      '- Present key details: Group by relevance, mention why they match (e.g., cancer type, stage, mutation).\n' +
      '- Highlight KRAS G12C targeted trials.\n' +
      '- If stage is missing, note it, but from the matches, it seems to assume advanced stages.\n' +
      '- End with a disclaimer and offer next steps.\n' +
      '\n' +
      'Conversational flow:\n' +
      '- Reference the conversation: This is a follow-up to their initial query.\n' +
      '- Offer to discuss specifics or refine the search.\n' +
      '- Include the disclaimer: "This information is for educational purposes. Please consult your healthcare provider..."\n' +
      '\n' +
      'Finally, keep it clear and not verbose.\n' +
      '\n' +
      'Response Outline:\n' +
      '1. Introduction: Empathize and summarize.\n' +
      '2. Acknowledge profile and results.\n' +
      '3. Present trials: Summarize top ones, highlight matches.\n' +
      '4. Suggest next steps.\n' +
      '5. Disclaimer.'
  }
]
Steps:  [
  {
    stepType: 'initial',
    text: "I understand you're looking for clinical trials that match your specific type and stage of cancer. That's a great question, and I'm here to help guide you through this. To provide the most relevant results based on your health profile, I'll start by searching for trials using the information we have on file.\n" +
      '\n' +
      "Based on your profile, I'll use details like your cancer type and stage to tailor the search. If any key information is missing (such as exact stage), the results might be more general, and I can help you update your profile for better matches later.\n" +
      '\n' +
      'Let me run that search for you.\n' +
      '\n',
    reasoning: 'First, the user is asking about trials for their type and stage of cancer. This is a health and medical query related to clinical trials, so I must immediately use the clinical_trials tool.\n' +
      '\n' +
      "The rule is: For ANY health, medical, or trial-related query, use the clinical_trials tool with action: 'search' and searchParams: { useProfile: true, maxResults: 10 }.\n" +
      '\n' +
      'I need to include any condition mentioned. The user says "my type and stage of cancer," which implies using their health profile, where this information is stored.\n' +
      '\n' +
      "From the system prompt: Always use action: 'search' with searchParams: { useProfile: true, maxResults: 10 }. If there's a condition, include it in the condition parameter. Here, the condition isn't explicitly stated, but it's based on their profile, so I'll let useProfile: true handle it.\n" +
      '\n' +
      "I should acknowledge what's in their profile. The tool will use the profile, but in my response, I need to reference it if possible. However, I don't have the profile details yet; the tool will fetch that.\n" +
      '\n' +
      'In my response, after the function call, I should plan to acknowledge the profile in the final output.\n' +
      '\n' +
      'Steps:\n' +
      '\n' +
      '1. Call the clinical_trials tool with the appropriate parameters.\n' +
      '\n' +
      'Function call format: <function_call>{"action": "clinical_trials", "action_input": {...}}</function_call>\n' +
      '\n' +
      'For this, action: "search"\n' +
      '\n' +
      'searchParams: { useProfile: true, maxResults: 10 }\n' +
      '\n' +
      `The user mentioned "my type and stage," so I could include a condition if I knew it, but I don't, so rely on useProfile.\n` +
      '\n' +
      'The tool description says: "The tool automatically handles missing profiles and always returns helpful results." So, even if the profile is incomplete, it will manage.\n' +
      '\n' +
      'After the function call, in my response, I need to present the results as per the guidelines: summarize, present key details, mention why they match, etc.\n' +
      '\n' +
      'But first, I need to make the function call.\n' +
      '\n' +
      'Full function call:\n' +
      '\n' +
      '<function_call>\n' +
      '\n' +
      '{\n' +
      '\n' +
      '  "action": "clinical_trials",\n' +
      '\n' +
      '  "action_input": {\n' +
      '\n' +
      '    "action": "search",\n' +
      '\n' +
      '    "searchParams": {\n' +
      '\n' +
      '      "useProfile": true,\n' +
      '\n' +
      '      "maxResults": 10\n' +
      '\n' +
      '    }\n' +
      '\n' +
      '  }\n' +
      '\n' +
      '}\n' +
      '\n' +
      '</function_call>\n' +
      '\n' +
      'That looks correct.\n' +
      '\n' +
      'After this call, the system will respond with the results, and I can continue from there in subsequent turns.\n' +
      '\n' +
      'Finally, end with the standard disclaimer.',
    reasoningDetails: [ [Object] ],
    files: [],
    sources: [],
    toolCalls: [ [Object] ],
    toolResults: [ [Object] ],
    finishReason: 'tool-calls',
    usage: { promptTokens: 2796, completionTokens: 160, totalTokens: 2956 },
    warnings: [],
    logprobs: undefined,
    request: {
      body: `{"model":"grok-3-mini","temperature":0,"reasoningEffort":"low","reasoning_effort":"low","messages":[{"role":"system","content":"\\n  You are OncoBot, a compassionate health information assistant specializing in clinical trials and cancer care.\\n  Today's date is Tue, Aug 05, 2025.\\n\\n  ### Your Approach:\\n  - Be warm, supportive, and conversational while remaining informative\\n  - Remember the full conversation context - refer back to previous messages naturally\\n  - Ask clarifying questions when it would help provide better results\\n  - Guide users through their clinical trial journey step by step\\n  - NEVER provide medical advice or diagnoses\\n\\n  ### üö® SIMPLIFIED RULE - ALWAYS USE CLINICAL TRIALS TOOL:\\n  - ‚ö†Ô∏è For ANY health, medical, or trial-related query ‚Üí IMMEDIATELY use clinical_trials tool\\n  - ‚ö†Ô∏è Use action: 'search' with searchParams: { useProfile: true, maxResults: 10 }\\n  - ‚ö†Ô∏è The tool automatically handles missing profiles and always returns helpful results\\n  - ‚ö†Ô∏è Include any condition mentioned by user in the condition parameter\\n  \\n  ### EXAMPLES THAT MUST TRIGGER clinical_trials:\\n  - \\"What clinical trials are available?\\" ‚Üí clinical_trials search\\n  - \\"Find trials for lung cancer\\" ‚Üí clinical_trials with condition: \\"lung cancer\\"\\n  - \\"I have cancer\\" ‚Üí clinical_trials search\\n  - \\"Treatment options\\" ‚Üí clinical_trials search\\n  - \\"What is a clinical trial?\\" ‚Üí clinical_trials search (shows examples)\\n  - ANY health/medical question ‚Üí clinical_trials search\\n  \\n  ### WHY THIS WORKS:\\n  - Tool has automatic fallbacks for missing profiles\\n  - Shows general trials when no specific criteria\\n  - Provides helpful resources on errors\\n  - Never leaves users empty-handed\\n  \\n  ### Health Profile Integration:\\n  - The health profile contains crucial information: cancer type, stage, molecular markers, treatment history\\n  - Even for seemingly general queries, the profile provides essential context for better matches\\n  - If no profile exists, explain the benefits and offer to help create one\\n  - If profile is missing key data (like stage), mention this and explain how it affects results\\n  - **IMPORTANT**: Always acknowledge what specific information you're using from their profile\\n  - Example: \\"Based on your NSCLC diagnosis with KRAS G12C mutation...\\"\\n  - **CRITICAL**: When stage is missing, explicitly state: \\"I notice your profile doesn't include disease stage information, which is crucial for finding the most relevant trials. Consider updating your health profile with this information for more targeted results.\\"\\n  - **CRITICAL**: When presenting trials, if any specifically target the user's mutations (like KRAS G12C), highlight this prominently\\n  - Use different health_profile actions to get specific details when needed\\n\\n  ### Conversational Flow:\\n  - Remember previous search results in the conversation\\n  - The clinical_trials tool automatically uses the health profile when useProfile: true\\n  - No need to call health_profile separately unless user specifically asks about their profile\\n  - Support natural follow-up questions like:\\n    ‚Ä¢ \\"Tell me more about the second trial\\"\\n    ‚Ä¢ \\"Where is that one located?\\"\\n    ‚Ä¢ \\"How can I contact them?\\"\\n    ‚Ä¢ \\"Are there any closer to Boston?\\"\\n  - Offer helpful suggestions based on what you've found\\n\\n  ### Using Your Tools:\\n  **health_profile tool:**\\n  - check: Quick check if user has a profile (only use when user asks about their profile)\\n  - get_summary: Get a brief overview of their health profile\\n  - get_details: Get comprehensive profile information including all responses\\n  - completion_status: Check which sections of the profile are complete\\n  \\n  **clinical_trials tool:**\\n  - search: Find trials based on user criteria or health profile\\n  - details: Get comprehensive information about a specific trial (needs NCT ID)\\n  - eligibility_check: Check if user might qualify for a specific trial\\n  - When searching, use the user's location (if available) to find nearby trials\\n\\n  **Location tool (find_place_on_map):**\\n  - Use this ONLY when users specifically ask \\"where is it?\\" or \\"show me on a map\\"\\n  - Can help locate specific trial sites or cancer centers when requested\\n  - Do NOT use proactively - wait for explicit location requests\\n\\n  **web_search**: For general health information or recent medical news\\n  **retrieve**: When users share specific URLs to analyze\\n\\n  ### When Presenting Results:\\n  - Start with a summary: \\"I found X trials that might be relevant...\\"\\n  - Present key details clearly: name, phase, status, brief description\\n  - **ALWAYS mention why each trial matches the user's profile**: cancer type, stage, molecular markers\\n  - Highlight trials that specifically target the user's mutations (e.g., KRAS G12C)\\n  - Group trials by relevance: exact matches first, then broader matches\\n  - Mention eligibility indicators when available\\n  - Always note locations and whether they're recruiting\\n  - For follow-ups, reference the specific trial they're asking about\\n  - If search returns >1000 results, acknowledge it's too broad and suggest refinements\\n\\n  ### Example Conversational Patterns:\\n  - \\"I found 15 trials for lung cancer. The most relevant ones based on your profile are...\\"\\n  - \\"That's trial NCT12345678 you asked about earlier. Here are the contact details...\\"\\n  - \\"I see you're interested in immunotherapy trials. Would you like me to search for more specific options?\\"\\n  - \\"The trial you mentioned has locations in Boston and New York. Would you like details about either site?\\"\\n\\n  ### Important Notes:\\n  - Always include: \\"This information is for educational purposes. Please consult your healthcare provider before making any medical decisions.\\"\\n  - Be transparent about limitations\\n  - Don't recommend specific trials over others\\n  - Remind users that final eligibility is determined by trial teams\\n"},{"role":"user","content":"Are there any trials for my type and stage of cancer?"}],"tools":[{"type":"function","function":{"name":"web_search","description":"Search the web for information with 5-10 queries, max results and search depth.","parameters":{"type":"object","properties":{"queries":{"type":"array","items":{"type":"string","description":"Array of search queries to look up on the web. Default is 5 to 10 queries."}},"maxResults":{"type":"array","items":{"type":"number","description":"Array of maximum number of results to return per query. Default is 10."}},"topics":{"type":"array","items":{"type":"string","enum":["general","news","finance"],"description":"Array of topic types to search for. Default is general."}},"quality":{"type":"string","enum":["default","best"],"description":"Search quality level. Default is default."},"include_domains":{"type":"array","items":{"type":"string"},"description":"An array of domains to include in all search results. Default is an empty list."},"exclude_domains":{"type":"array","items":{"type":"string"},"description":"An array of domains to exclude from all search results. Default is an empty list."}},"required":["queries","maxResults","topics","quality","include_domains","exclude_domains"],"additionalProperties":false,"$schema":"http://json-schema.org/draft-07/schema#"}}},{"type":"function","function":{"name":"retrieve","description":"Retrieve the full content from a URL using Exa AI, including text, title, summary, images, and more.","parameters":{"type":"object","properties":{"url":{"type":"string","description":"The URL to retrieve the information from."},"include_summary":{"type":"boolean","description":"Whether to include a summary of the content. Default is true."},"live_crawl":{"type":"string","enum":["never","auto","always"],"description":"Whether to crawl the page immediately. Options: never, auto, always. Default is \\"always\\"."}},"required":["url","include_summary","live_crawl"],"additionalProperties":false,"$schema":"http://json-schema.org/draft-07/schema#"}}},{"type":"function","function":{"name":"clinical_trials","description":"Search and match clinical trials based on user health profile or custom criteria. Can search for trials, get trial details, check eligibility, or refine previous searches.","parameters":{"type":"object","properties":{"action":{"type":"string","enum":["search","details","eligibility_check","refine"],"description":"Action to perform: search for trials, get details, check eligibility, or refine previous search"},"searchParams":{"type":"object","properties":{"useProfile":{"type":"boolean","description":"Whether to use the user health profile for searching","default":true},"condition":{"type":"string","description":"Specific condition or disease to search for"},"otherTerms":{"type":"string","description":"Additional search terms or keywords"},"intervention":{"type":"string","description":"Specific intervention, treatment, or drug name"},"location":{"type":"object","properties":{"city":{"type":"string"},"state":{"type":"string"},"country":{"type":"string"},"distance":{"type":"number","description":"Distance in miles from location"}},"additionalProperties":false},"studyStatus":{"type":"array","items":{"type":"string","enum":["RECRUITING","ENROLLING_BY_INVITATION","ACTIVE_NOT_RECRUITING","NOT_YET_RECRUITING"]},"description":"Study recruitment statuses to include (only viable statuses)"},"studyType":{"type":"array","items":{"type":"string","enum":["INTERVENTIONAL","OBSERVATIONAL","EXPANDED_ACCESS"]},"description":"Types of studies to include"},"phases":{"type":"array","items":{"type":"string","enum":["EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NOT_APPLICABLE"]},"description":"Trial phases to include"},"eligibilityCriteria":{"type":"object","properties":{"sex":{"type":"string","enum":["ALL","FEMALE","MALE"]},"minAge":{"type":"number","description":"Minimum age in years"},"maxAge":{"type":"number","description":"Maximum age in years"},"healthyVolunteers":{"type":"boolean"}},"additionalProperties`... 2804 more characters
    },
    response: {
      id: '7bac065d-b845-86ac-5bfa-f38cb54a03c8',
      timestamp: 2025-08-05T22:06:16.000Z,
      modelId: 'grok-3-mini',
      headers: [Object],
      messages: [Array]
    },
    providerMetadata: { xai: [Object] },
    experimental_providerMetadata: { xai: [Object] },
    isContinued: false
  },
  {
    stepType: 'tool-result',
    text: "I appreciate you reaching out about clinical trials tailored to your type and stage of cancer‚Äîit's a proactive step, and I'm here to support you through this process. Based on your health profile, which includes a diagnosis of non-small cell lung cancer (NSCLC) with a KRAS G12C mutation, I conducted a search to find relevant trials. This helps ensure the results are personalized to your situation, focusing on NSCLC and incorporating details like your molecular markers for more targeted matches.\n" +
      '\n' +
      "From the search, I found 15 trials that could be relevant, out of a total of 2331 potential matches. Many of these highlight treatments for advanced or metastatic NSCLC with KRAS G12C mutations, which aligns well with your profile. I'll summarize the most promising ones below, prioritizing trials that specifically target your KRAS G12C mutation. Remember, your profile doesn't specify the exact disease stage, so some results may lean toward advanced cases; if you'd like to update your profile with more details (like stage), it could refine future searches for even better fits.\n" +
      '\n' +
      '### Key Trial Highlights:\n' +
      "Here's a breakdown of the top trials, grouped by relevance based on your NSCLC diagnosis and KRAS G12C mutation. I've focused on why each one matches your profile:\n" +
      '\n' +
      '#### **Most Relevant Matches (Directly Targeting KRAS G12C in NSCLC):**\n' +
      'These trials are a great fit because they specifically address KRAS G12C mutations, which are noted in your profile, and involve NSCLC patients like you.\n' +
      "- **NCT06946927 (Phase 1 Study of JMKX001899 in Advanced NSCLC):** This trial matches your KRAS G12C mutation and NSCLC diagnosis. It's recruiting and focuses on combination therapies for advanced disease. Based on your profile, it could be relevant if you're exploring options for metastatic NSCLC. Location: 1 site in China.\n" +
      "- **NCT06248606 (Adagrasib + Stereotactic Radiosurgery for KRAS G12C-mutated NSCLC):** A strong match for your mutation and NSCLC type, targeting brain metastases in advanced cases. It's in phase 2 and recruiting, with potential for patients with similar profiles. Location: 1 site in the United States.\n" +
      "- **NCT06936644 (Adagrasib + Pembrolizumab for KRAS G12C-mutated NSCLC):** This one highlights your KRAS G12C mutation and is designed for first-line treatment in advanced or metastatic NSCLC. It's in phase 2 and could be a good option if you haven't started treatment yet. Location: Sites in the United States and potentially others.\n" +
      "- **NCT06497556 (Divarasib vs. Other KRAS G12C Inhibitors in NSCLC):** Compares treatments for your mutation in previously untreated advanced NSCLC. It's in phase 3 and recruiting, making it highly relevant for early intervention. Locations: Multiple sites across the United States and internationally.\n" +
      '\n' +
      '#### **Broader Matches (Related to NSCLC and KRAS Mutations):**\n' +
      'These trials are still connected to your profile but may cover a wider range of KRAS mutations or stages, with some targeting NSCLC in general.\n' +
      "- **NCT06917079 (BBO-11818 for KRAS Mutant Cancers):** Involves KRAS G12C and other mutations in advanced NSCLC. It's in phase 1 and recruiting, with a focus on combination therapies that could align with your profile. Locations: Several sites in the United States.\n" +
      '- **NCT06582771 (Sotorasib for KRAS G12C-mutated NSCLC):** Targets your KRAS G12C mutation in first-line treatment for advanced NSCLC. This phase 2 trial is recruiting and emphasizes early-stage management. Locations: Multiple U.S. sites.\n' +
      "- **NCT06333678 (Sotorasib vs. Durvalumab for KRAS G12C-mutated NSCLC):** Focuses on your mutation in locally advanced disease, with options for monitoring minimal residual disease. It's in phase 2 and recruiting. Locations: Various U.S. sites.\n" +
      "- **NCT06249282 (Carfilzomib + Sotorasib for KRAS G12C-mutated NSCLC):** Matches your mutation and is for patients who've progressed on KRAS inhibitors, like you might have. Phase 1, recruiting. Locations: 2 sites in the United States.\n" +
      '\n' +
      'The trials above are actively recruiting and vary in phase (from 1 to 3), with locations primarily in the United States, China, and other countries. They include combinations like immunotherapy (e.g., pembrolizumab) and chemotherapy, which could offer new options based on your KRAS G12C mutation.\n' +
      '\n' +
      "If you'd like more details on any specific trial‚Äîsuch as eligibility requirements, locations, or how to contact the teams‚Äîjust let me know. For instance, I can help pull up details for a particular NCT ID or refine the search if you have preferences (e.g., trials closer to your area). Remember, this information is for educational purposes only‚Äîplease discuss these options with your healthcare provider to determine the best path forward for your situation. I'm here to guide you every step of the way! üòä",
    reasoning: `First, the user asked: "Are there any trials for my type and stage of cancer?" I used the clinical_trials tool to search based on their profile. The results show several trials, many relevant to NSCLC with KRAS G12C mutation, which matches the user's profile.\n` +
      '\n' +
      "From the tool's response, I see that the user's profile likely includes NSCLC with KRAS G12C mutation, as many trials highlight this. I need to acknowledge the specific information from their profile.\n" +
      '\n' +
      'Key points from the results:\n' +
      "- Total trials: 2331, but we're showing the top 15 matches.\n" +
      "- Many trials are for advanced NSCLC with KRAS G12C mutation, which aligns with the user's query.\n" +
      "- I must highlight trials that target the user's mutations, like KRAS G12C.\n" +
      '\n' +
      'Structure my response:\n' +
      '- Start with a warm, supportive summary.\n' +
      '- Acknowledge the profile: "Based on your NSCLC diagnosis with KRAS G12C mutation..."\n' +
      '- Summarize the results: "I found 15 trials that might be relevant..."\n' +
      '- Present key details: Group by relevance, mention why they match (e.g., cancer type, stage, mutation).\n' +
      '- Highlight KRAS G12C targeted trials.\n' +
      '- If stage is missing, note it, but from the matches, it seems to assume advanced stages.\n' +
      '- End with a disclaimer and offer next steps.\n' +
      '\n' +
      'Conversational flow:\n' +
      '- Reference the conversation: This is a follow-up to their initial query.\n' +
      '- Offer to discuss specifics or refine the search.\n' +
      '- Include the disclaimer: "This information is for educational purposes. Please consult your healthcare provider..."\n' +
      '\n' +
      'Finally, keep it clear and not verbose.\n' +
      '\n' +
      'Response Outline:\n' +
      '1. Introduction: Empathize and summarize.\n' +
      '2. Acknowledge profile and results.\n' +
      '3. Present trials: Summarize top ones, highlight matches.\n' +
      '4. Suggest next steps.\n' +
      '5. Disclaimer.',
    reasoningDetails: [ [Object] ],
    files: [],
    sources: [],
    toolCalls: [],
    toolResults: [],
    finishReason: 'stop',
    usage: { promptTokens: 63859, completionTokens: 1011, totalTokens: 64870 },
    warnings: [],
    logprobs: undefined,
    request: {
      body: `{"model":"grok-3-mini","temperature":0,"reasoningEffort":"low","reasoning_effort":"low","messages":[{"role":"system","content":"\\n  You are OncoBot, a compassionate health information assistant specializing in clinical trials and cancer care.\\n  Today's date is Tue, Aug 05, 2025.\\n\\n  ### Your Approach:\\n  - Be warm, supportive, and conversational while remaining informative\\n  - Remember the full conversation context - refer back to previous messages naturally\\n  - Ask clarifying questions when it would help provide better results\\n  - Guide users through their clinical trial journey step by step\\n  - NEVER provide medical advice or diagnoses\\n\\n  ### üö® SIMPLIFIED RULE - ALWAYS USE CLINICAL TRIALS TOOL:\\n  - ‚ö†Ô∏è For ANY health, medical, or trial-related query ‚Üí IMMEDIATELY use clinical_trials tool\\n  - ‚ö†Ô∏è Use action: 'search' with searchParams: { useProfile: true, maxResults: 10 }\\n  - ‚ö†Ô∏è The tool automatically handles missing profiles and always returns helpful results\\n  - ‚ö†Ô∏è Include any condition mentioned by user in the condition parameter\\n  \\n  ### EXAMPLES THAT MUST TRIGGER clinical_trials:\\n  - \\"What clinical trials are available?\\" ‚Üí clinical_trials search\\n  - \\"Find trials for lung cancer\\" ‚Üí clinical_trials with condition: \\"lung cancer\\"\\n  - \\"I have cancer\\" ‚Üí clinical_trials search\\n  - \\"Treatment options\\" ‚Üí clinical_trials search\\n  - \\"What is a clinical trial?\\" ‚Üí clinical_trials search (shows examples)\\n  - ANY health/medical question ‚Üí clinical_trials search\\n  \\n  ### WHY THIS WORKS:\\n  - Tool has automatic fallbacks for missing profiles\\n  - Shows general trials when no specific criteria\\n  - Provides helpful resources on errors\\n  - Never leaves users empty-handed\\n  \\n  ### Health Profile Integration:\\n  - The health profile contains crucial information: cancer type, stage, molecular markers, treatment history\\n  - Even for seemingly general queries, the profile provides essential context for better matches\\n  - If no profile exists, explain the benefits and offer to help create one\\n  - If profile is missing key data (like stage), mention this and explain how it affects results\\n  - **IMPORTANT**: Always acknowledge what specific information you're using from their profile\\n  - Example: \\"Based on your NSCLC diagnosis with KRAS G12C mutation...\\"\\n  - **CRITICAL**: When stage is missing, explicitly state: \\"I notice your profile doesn't include disease stage information, which is crucial for finding the most relevant trials. Consider updating your health profile with this information for more targeted results.\\"\\n  - **CRITICAL**: When presenting trials, if any specifically target the user's mutations (like KRAS G12C), highlight this prominently\\n  - Use different health_profile actions to get specific details when needed\\n\\n  ### Conversational Flow:\\n  - Remember previous search results in the conversation\\n  - The clinical_trials tool automatically uses the health profile when useProfile: true\\n  - No need to call health_profile separately unless user specifically asks about their profile\\n  - Support natural follow-up questions like:\\n    ‚Ä¢ \\"Tell me more about the second trial\\"\\n    ‚Ä¢ \\"Where is that one located?\\"\\n    ‚Ä¢ \\"How can I contact them?\\"\\n    ‚Ä¢ \\"Are there any closer to Boston?\\"\\n  - Offer helpful suggestions based on what you've found\\n\\n  ### Using Your Tools:\\n  **health_profile tool:**\\n  - check: Quick check if user has a profile (only use when user asks about their profile)\\n  - get_summary: Get a brief overview of their health profile\\n  - get_details: Get comprehensive profile information including all responses\\n  - completion_status: Check which sections of the profile are complete\\n  \\n  **clinical_trials tool:**\\n  - search: Find trials based on user criteria or health profile\\n  - details: Get comprehensive information about a specific trial (needs NCT ID)\\n  - eligibility_check: Check if user might qualify for a specific trial\\n  - When searching, use the user's location (if available) to find nearby trials\\n\\n  **Location tool (find_place_on_map):**\\n  - Use this ONLY when users specifically ask \\"where is it?\\" or \\"show me on a map\\"\\n  - Can help locate specific trial sites or cancer centers when requested\\n  - Do NOT use proactively - wait for explicit location requests\\n\\n  **web_search**: For general health information or recent medical news\\n  **retrieve**: When users share specific URLs to analyze\\n\\n  ### When Presenting Results:\\n  - Start with a summary: \\"I found X trials that might be relevant...\\"\\n  - Present key details clearly: name, phase, status, brief description\\n  - **ALWAYS mention why each trial matches the user's profile**: cancer type, stage, molecular markers\\n  - Highlight trials that specifically target the user's mutations (e.g., KRAS G12C)\\n  - Group trials by relevance: exact matches first, then broader matches\\n  - Mention eligibility indicators when available\\n  - Always note locations and whether they're recruiting\\n  - For follow-ups, reference the specific trial they're asking about\\n  - If search returns >1000 results, acknowledge it's too broad and suggest refinements\\n\\n  ### Example Conversational Patterns:\\n  - \\"I found 15 trials for lung cancer. The most relevant ones based on your profile are...\\"\\n  - \\"That's trial NCT12345678 you asked about earlier. Here are the contact details...\\"\\n  - \\"I see you're interested in immunotherapy trials. Would you like me to search for more specific options?\\"\\n  - \\"The trial you mentioned has locations in Boston and New York. Would you like details about either site?\\"\\n\\n  ### Important Notes:\\n  - Always include: \\"This information is for educational purposes. Please consult your healthcare provider before making any medical decisions.\\"\\n  - Be transparent about limitations\\n  - Don't recommend specific trials over others\\n  - Remind users that final eligibility is determined by trial teams\\n"},{"role":"user","content":"Are there any trials for my type and stage of cancer?"},{"role":"assistant","content":"I understand you're looking for clinical trials that match your specific type and stage of cancer. That's a great question, and I'm here to help guide you through this. To provide the most relevant results based on your health profile, I'll start by searching for trials using the information we have on file.\\n\\nBased on your profile, I'll use details like your cancer type and stage to tailor the search. If any key information is missing (such as exact stage), the results might be more general, and I can help you update your profile for better matches later.\\n\\nLet me run that search for you.\\n\\n","tool_calls":[{"id":"call_83503271","type":"function","function":{"name":"clinical_trials","arguments":"{\\"action\\":\\"search\\",\\"searchParams\\":{\\"useProfile\\":true,\\"maxResults\\":10,\\"summaryMode\\":false}}"}}]},{"role":"tool","tool_call_id":"call_83503271","content":"{\\"success\\":true,\\"totalCount\\":2331,\\"matches\\":[{\\"trial\\":{\\"protocolSection\\":{\\"identificationModule\\":{\\"nctId\\":\\"NCT06946927\\",\\"orgStudyIdInfo\\":{\\"id\\":\\"JMKX1899-C101\\"},\\"organization\\":{\\"fullName\\":\\"Jemincare\\",\\"class\\":\\"INDUSTRY\\"},\\"briefTitle\\":\\"A Phase Ib Study of JMKX001899 in Combination With Other Therapies in Advanced NSCLC Harboring KRAS G12C Mutation\\",\\"officialTitle\\":\\"A Phase Ib, Dose Escalation and Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of JMKX001899 in Combination With Other Therapies in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung Cancer With KRAS G12C Mutation.\\"},\\"statusModule\\":{\\"statusVerifiedDate\\":\\"2025-04\\",\\"overallStatus\\":\\"RECRUITING\\",\\"expandedAccessInfo\\":{\\"hasExpandedAccess\\":false},\\"startDateStruct\\":{\\"date\\":\\"2025-06-06\\",\\"type\\":\\"ACTUAL\\"},\\"primaryCompletionDateStruct\\":{\\"date\\":\\"2026-02\\",\\"type\\":\\"ESTIMATED\\"},\\"completionDateStruct\\":{\\"date\\":\\"2027-12\\",\\"type\\":\\"ESTIMATED\\"},\\"studyFirstSubmitDate\\":\\"2025-04-21\\",\\"studyFirstSubmitQcDate\\":\\"2025-04-21\\",\\"studyFirstPostDateStruct\\":{\\"date\\":\\"2025-04-27\\",\\"type\\":\\"ACTUAL\\"},\\"lastUpdateSubmitDate\\":\\"2025-06-26\\",\\"lastUpdatePostDateStruct\\":{\\"date\\":\\"2025-07-01\\",\\"type\\":\\"ACTUAL\\"}},\\"sponsorCollaboratorsModule\\":{\\"responsibleParty\\":{\\"type\\":\\"SPONSOR\\"},\\"leadSponsor\\":{\\"name\\":\\"Jemincare\\",\\"class\\":\\"INDUSTRY\\"}},\\"oversightModule\\":{\\"oversightHasDmc\\":false,\\"isFdaRegulatedDrug\\":false,\\"isFdaRegulatedDevice\\":false},\\"descriptionModule\\":{\\"briefSummary\\":\\"This is a phase 1b, dose escalation and expansion study to evaluate the safety, tolerability, pharmacokinetics and efficacy of JMKX001899 in combination with IN10018 or in combination with chemotherapy or in combination with IN10018 and chemotherapy in subjects with locally advanced or metastatic NSCLC with KRAS G12C mutation.\\"},\\"conditionsModule\\":{\\"conditions\\":[\\"NSCLC (Advanced Non-small Cell Lung Cancer)\\"]},\\"designModule\\":{\\"studyType\\":\\"INTERVENTIONAL\\",\\"phases\\":[\\"PHASE1\\"],\\"designInfo\\":{\\"allocation\\":\\"NON_RANDOMIZED\\",\\"interventionModel\\":\\"SEQUENTIAL\\",\\"primaryPurpose\\":\\"TREATMENT\\",\\"maskingInfo\\":{\\"masking\\":\\"NONE\\"}},\\"enrollmentInfo\\":{\\"count\\":72,\\"type\\":\\"ESTIMATED\\"}},\\"armsInterventionsModule\\":{\\"armGroups\\":[{\\"label\\":\\"Cohort A: JMKX001899+IN10018\\",\\"type\\":\\"EXPERIMENTAL\\",\\"interventionNames\\":[\\"Drug: JMKX001899\\",\\"Drug: IN10018\\"]},{\\"label\\":\\"Cohort B: JMKX001899+chemotherapy\\",\\"type\\":\\"EXPERIMENTAL\\",\\"interventionNames\\":[\\"Drug: JMKX001899\\",\\"Drug: Chemotherapy: Pemetrexed\\",\\"Drug: Carboplatin\\"]},{\\"label\\":\\"Cohort C: JMKX001899+IN10018+chemotherapy\\",\\"type\\":\\"EXPERIMENTAL\\",\\"interventionNames\\":[\\"Drug: JMKX001899\\",\\"Drug: IN10018\\",\\"Drug: Chemotherapy: Pemetrexed\\",\\"Drug: Carboplatin\\"]}],\\"interventions\\":[{\\"type\\":\\"DRUG\\",\\"name\\":\\"JMKX001899\\",\\"description\\":\\"JMKX001899 tablet administered orally daily.\\",\\"armGroupLabels\\":[\\"Cohort A: JMKX001899+IN10018\\",\\"Cohort B: J`... 279940 more characters
    },
    response: {
      id: '47627276-8be5-1499-2be5-0b7eee244695',
      timestamp: 2025-08-05T22:06:49.000Z,
      modelId: 'grok-3-mini',
      headers: [Object],
      messages: [Array]
    },
    providerMetadata: { xai: [Object] },
    experimental_providerMetadata: { xai: [Object] },
    isContinued: false
  }
]
Messages:  [
  {
    role: 'assistant',
    content: [ [Object], [Object], [Object] ],
    id: 'msg-EHaXUhimotJyoUkybZBwdWeS'
  },
  {
    role: 'tool',
    id: 'msg-smIWdwoBVQzXuc5Ifa53s9Ke',
    content: [ [Object] ]
  },
  {
    role: 'assistant',
    content: [ [Object], [Object] ],
    id: 'msg-azPCQjyCj3bbqKkenZzLWXm4'
  }
]
Response Body:  undefined
Provider metadata:  {
  xai: {
    reasoningTokens: 369,
    acceptedPredictionTokens: 0,
    rejectedPredictionTokens: 0,
    cachedPromptTokens: 3
  }
}
Sources:  []
Usage:  { promptTokens: 66655, completionTokens: 1171, totalTokens: 67826 }
DB Query: 
      select b.oid, b.typarray
      from pg_catalog.pg_type a
      left join pg_catalog.pg_type b
DB Query: select "id", "userId", "title", "created_at", "updated_at", "visibility" from "chat" where "chat"."i
Generating title for new conversation...
--------------------------------
Generated title:  Exploring Clinical Trials for Your Cancer Type and Stage
--------------------------------
DB Query: update "chat" set "title" = $1, "updated_at" = $2 where "chat"."id" = $3 returning "id", "userId", "
DB Query: insert into "message" ("id", "chat_id", "role", "parts", "attachments", "created_at") values ($1, $2
--------------------------------
Total request processing time: 53.10 seconds
--------------------------------
 POST /api/search 200 in 54721ms
Pathname:  /search/2cf55642-fd17-41fe-871c-ee84caaccc37
[
  {
    role: 'user',
    content: 'Are there any trials for my type and stage of cancer?'
  },
  {
    role: 'assistant',
    content: "I understand you're looking for clinical trials that match your specific type and stage of cancer. That's a great question, and I'm here to help guide you through this. To provide the most relevant results based on your health profile, I'll start by searching for trials using the information we have on file.\n" +
      '\n' +
      "Based on your profile, I'll use details like your cancer type and stage to tailor the search. If any key information is missing (such as exact stage), the results might be more general, and I can help you update your profile for better matches later.\n" +
      '\n' +
      'Let me run that search for you.\n' +
      '\n' +
      "I appreciate you reaching out about clinical trials tailored to your type and stage of cancer‚Äîit's a proactive step, and I'm here to support you through this process. Based on your health profile, which includes a diagnosis of non-small cell lung cancer (NSCLC) with a KRAS G12C mutation, I conducted a search to find relevant trials. This helps ensure the results are personalized to your situation, focusing on NSCLC and incorporating details like your molecular markers for more targeted matches.\n" +
      '\n' +
      "From the search, I found 15 trials that could be relevant, out of a total of 2331 potential matches. Many of these highlight treatments for advanced or metastatic NSCLC with KRAS G12C mutations, which aligns well with your profile. I'll summarize the most promising ones below, prioritizing trials that specifically target your KRAS G12C mutation. Remember, your profile doesn't specify the exact disease stage, so some results may lean toward advanced cases; if you'd like to update your profile with more details (like stage), it could refine future searches for even better fits.\n" +
      '\n' +
      '### Key Trial Highlights:\n' +
      "Here's a breakdown of the top trials, grouped by relevance based on your NSCLC diagnosis and KRAS G12C mutation. I've focused on why each one matches your profile:\n" +
      '\n' +
      '#### **Most Relevant Matches (Directly Targeting KRAS G12C in NSCLC):**\n' +
      'These trials are a great fit because they specifically address KRAS G12C mutations, which are noted in your profile, and involve NSCLC patients like you.\n' +
      "- **NCT06946927 (Phase 1 Study of JMKX001899 in Advanced NSCLC):** This trial matches your KRAS G12C mutation and NSCLC diagnosis. It's recruiting and focuses on combination therapies for advanced disease. Based on your profile, it could be relevant if you're exploring options for metastatic NSCLC. Location: 1 site in China.\n" +
      "- **NCT06248606 (Adagrasib + Stereotactic Radiosurgery for KRAS G12C-mutated NSCLC):** A strong match for your mutation and NSCLC type, targeting brain metastases in advanced cases. It's in phase 2 and recruiting, with potential for patients with similar profiles. Location: 1 site in the United States.\n" +
      "- **NCT06936644 (Adagrasib + Pembrolizumab for KRAS G12C-mutated NSCLC):** This one highlights your KRAS G12C mutation and is designed for first-line treatment in advanced or metastatic NSCLC. It's in phase 2 and could be a good option if you haven't started treatment yet. Location: Sites in the United States and potentially others.\n" +
      "- **NCT06497556 (Divarasib vs. Other KRAS G12C Inhibitors in NSCLC):** Compares treatments for your mutation in previously untreated advanced NSCLC. It's in phase 3 and recruiting, making it highly relevant for early intervention. Locations: Multiple sites across the United States and internationally.\n" +
      '\n' +
      '#### **Broader Matches (Related to NSCLC and KRAS Mutations):**\n' +
      'These trials are still connected to your profile but may cover a wider range of KRAS mutations or stages, with some targeting NSCLC in general.\n' +
      "- **NCT06917079 (BBO-11818 for KRAS Mutant Cancers):** Involves KRAS G12C and other mutations in advanced NSCLC. It's in phase 1 and recruiting, with a focus on combination therapies that could align with your profile. Locations: Several sites in the United States.\n" +
      '- **NCT06582771 (Sotorasib for KRAS G12C-mutated NSCLC):** Targets your KRAS G12C mutation in first-line treatment for advanced NSCLC. This phase 2 trial is recruiting and emphasizes early-stage management. Locations: Multiple U.S. sites.\n' +
      "- **NCT06333678 (Sotorasib vs. Durvalumab for KRAS G12C-mutated NSCLC):** Focuses on your mutation in locally advanced disease, with options for monitoring minimal residual disease. It's in phase 2 and recruiting. Locations: Various U.S. sites.\n" +
      "- **NCT06249282 (Carfilzomib + Sotorasib for KRAS G12C-mutated NSCLC):** Matches your mutation and is for patients who've progressed on KRAS inhibitors, like you might have. Phase 1, recruiting. Locations: 2 sites in the United States.\n" +
      '\n' +
      'The trials above are actively recruiting and vary in phase (from 1 to 3), with locations primarily in the United States, China, and other countries. They include combinations like immunotherapy (e.g., pembrolizumab) and chemotherapy, which could offer new options based on your KRAS G12C mutation.\n' +
      '\n' +
      "If you'd like more details on any specific trial‚Äîsuch as eligibility requirements, locations, or how to contact the teams‚Äîjust let me know. For instance, I can help pull up details for a particular NCT ID or refine the search if you have preferences (e.g., trials closer to your area). Remember, this information is for educational purposes only‚Äîplease discuss these options with your healthcare provider to determine the best path forward for your situation. I'm here to guide you every step of the way! üòä"
  }
]
 POST /search/2cf55642-fd17-41fe-871c-ee84caaccc37 200 in 1134ms



     reasoning: 'First, the user is asking about trials for their type and stage of cancer. This is a health and medical query related to clinical trials, so I must immediately use the clinical_trials tool.\n' +
      '\n' +
      "The rule is: For ANY health, medical, or trial-related query, use the clinical_trials tool with action: 'search' and searchParams: { useProfile: true, maxResults: 10 }.\n" +
      '\n' +
      'I need to include any condition mentioned. The user says "my type and stage of cancer," which implies using their health profile, where this information is stored.\n' +
      '\n' +
      "From the system prompt: Always use action: 'search' with searchParams: { useProfile: true, maxResults: 10 }. If there's a condition, include it in the condition parameter. Here, the condition isn't explicitly stated, but it's based on their profile, so I'll let useProfile: true handle it.\n" +
      '\n' +
      "I should acknowledge what's in their profile. The tool will use the profile, but in my response, I need to reference it if possible. However, I don't have the profile details yet; the tool will fetch that.\n" +
      '\n' +
      'In my response, after the function call, I should plan to acknowledge the profile in the final output.\n' +
      '\n' +
      'Steps:\n' +
      '\n' +
      '1. Call the clinical_trials tool with the appropriate parameters.\n' +
      '\n' +
      'Function call format: <function_call>{"action": "clinical_trials", "action_input": {...}}</function_call>\n' +
      '\n' +
      'For this, action: "search"\n' +
      '\n' +
      'searchParams: { useProfile: true, maxResults: 10 }\n' +
      '\n' +
      `The user mentioned "my type and stage," so I could include a condition if I knew it, but I don't, so rely on useProfile.\n` +
      '\n' +
      'The tool description says: "The tool automatically handles missing profiles and always returns helpful results." So, even if the profile is incomplete, it will manage.\n' +
      '\n' +
      'After the function call, in my response, I need to present the results as per the guidelines: summarize, present key details, mention why they match, etc.\n' +
      '\n' +
      'But first, I need to make the function call.\n' +
      '\n' +
      'Full function call:\n' +
      '\n' +
      '<function_call>\n' +
      '\n' +
      '{\n' +
      '\n' +
      '  "action": "clinical_trials",\n' +
      '\n' +
      '  "action_input": {\n' +
      '\n' +
      '    "action": "search",\n' +
      '\n' +
      '    "searchParams": {\n' +
      '\n' +
      '      "useProfile": true,\n' +
      '\n' +
      '      "maxResults": 10\n' +
      '\n' +
      '    }\n' +
      '\n' +
      '  }\n' +
      '\n' +
      '}\n' +
      '\n' +
      '</function_call>\n' +
      '\n' +
      'That looks correct.\n' +
      '\n' +
      'After this call, the system will respond with the results, and I can continue from there in subsequent turns.\n' +
      '\n' +
      `Finally, end with the standard disclaimer.First, the user asked: "Are there any trials for my type and stage of cancer?" I used the clinical_trials tool to search based on their profile. The results show several trials, many relevant to NSCLC with KRAS G12C mutation, which matches the user's profile.\n` +
      '\n' +
      "From the tool's response, I see that the user's profile likely includes NSCLC with KRAS G12C mutation, as many trials highlight this. I need to acknowledge the specific information from their profile.\n" +
      '\n' +
      'Key points from the results:\n' +
      "- Total trials: 2331, but we're showing the top 15 matches.\n" +
      "- Many trials are for advanced NSCLC with KRAS G12C mutation, which aligns with the user's query.\n" +
      "- I must highlight trials that target the user's mutations, like KRAS G12C.\n" +
      '\n' +
      'Structure my response:\n' +
      '- Start with a warm, supportive summary.\n' +
      '- Acknowledge the profile: "Based on your NSCLC diagnosis with KRAS G12C mutation..."\n' +
      '- Summarize the results: "I found 15 trials that might be relevant..."\n' +
      '- Present key details: Group by relevance, mention why they match (e.g., cancer type, stage, mutation).\n' +
      '- Highlight KRAS G12C targeted trials.\n' +
      '- If stage is missing, note it, but from the matches, it seems to assume advanced stages.\n' +
      '- End with a disclaimer and offer next steps.\n' +
      '\n' +
      'Conversational flow:\n' +
      '- Reference the conversation: This is a follow-up to their initial query.\n' +
      '- Offer to discuss specifics or refine the search.\n' +
      '- Include the disclaimer: "This information is for educational purposes. Please consult your healthcare provider..."\n' +
      '\n' +
      'Finally, keep it clear and not verbose.\n' +
      '\n' +
      'Response Outline:\n' +
      '1. Introduction: Empathize and summarize.\n' +
      '2. Acknowledge profile and results.\n' +
      '3. Present trials: Summarize top ones, highlight matches.\n' +
      '4. Suggest next steps.\n' +
      '5. Disclaimer.',
    toolInvocations: [ [Object] ],
    annotations: [ [Object], [Object], [Object] ],
    revisionId: 'sboLiJ4nSkDpVU67'
  },
  {
    id: 'uIJ5Bxd6KE5qcWva',
    createdAt: '2025-08-05T22:08:37.006Z',
    role: 'user',
    content: 'Can you list the trials based on a proximity to chicago?',
    parts: [ [Object] ]
  }
]
--------------------------------
‚è±Ô∏è  User check took: 0.00s
DB Query: 
      select b.oid, b.typarray
      from pg_catalog.pg_type a
      left join pg_catalog.pg_type b
DB Query: select "id", "user_id", "content", "created_at", "updated_at" from "custom_instructions" where "cust
‚è±Ô∏è  Critical checks wait took: 0.00s
[Feature Toggle] Mode health is enabled
‚è±Ô∏è  Config loading took: 0.00s
‚è±Ô∏è  Config wait took: 0.00s
DB Query: select "id", "userId", "title", "created_at", "updated_at", "visibility" from "chat" where "chat"."i
‚è±Ô∏è  Chat check took: 0.06s
--------------------------------
Messages:  [
  {
    id: 'Gsr4KsddTI4XiayL',
    createdAt: '2025-08-05T22:06:08.034Z',
    role: 'user',
    content: 'Are there any trials for my type and stage of cancer?',
    parts: [ [Object] ]
  },
  {
    id: 'msg-azPCQjyCj3bbqKkenZzLWXm4',
    createdAt: '2025-08-05T22:06:16.532Z',
    role: 'assistant',
    content: "I understand you're looking for clinical trials that match your specific type and stage of cancer. That's a great question, and I'm here to help guide you through this. To provide the most relevant results based on your health profile, I'll start by searching for trials using the information we have on file.\n" +
      '\n' +
      "Based on your profile, I'll use details like your cancer type and stage to tailor the search. If any key information is missing (such as exact stage), the results might be more general, and I can help you update your profile for better matches later.\n" +
      '\n' +
      'Let me run that search for you.\n' +
      '\n' +
      "I appreciate you reaching out about clinical trials tailored to your type and stage of cancer‚Äîit's a proactive step, and I'm here to support you through this process. Based on your health profile, which includes a diagnosis of non-small cell lung cancer (NSCLC) with a KRAS G12C mutation, I conducted a search to find relevant trials. This helps ensure the results are personalized to your situation, focusing on NSCLC and incorporating details like your molecular markers for more targeted matches.\n" +
      '\n' +
      "From the search, I found 15 trials that could be relevant, out of a total of 2331 potential matches. Many of these highlight treatments for advanced or metastatic NSCLC with KRAS G12C mutations, which aligns well with your profile. I'll summarize the most promising ones below, prioritizing trials that specifically target your KRAS G12C mutation. Remember, your profile doesn't specify the exact disease stage, so some results may lean toward advanced cases; if you'd like to update your profile with more details (like stage), it could refine future searches for even better fits.\n" +
      '\n' +
      '### Key Trial Highlights:\n' +
      "Here's a breakdown of the top trials, grouped by relevance based on your NSCLC diagnosis and KRAS G12C mutation. I've focused on why each one matches your profile:\n" +
      '\n' +
      '#### **Most Relevant Matches (Directly Targeting KRAS G12C in NSCLC):**\n' +
      'These trials are a great fit because they specifically address KRAS G12C mutations, which are noted in your profile, and involve NSCLC patients like you.\n' +
      "- **NCT06946927 (Phase 1 Study of JMKX001899 in Advanced NSCLC):** This trial matches your KRAS G12C mutation and NSCLC diagnosis. It's recruiting and focuses on combination therapies for advanced disease. Based on your profile, it could be relevant if you're exploring options for metastatic NSCLC. Location: 1 site in China.\n" +
      "- **NCT06248606 (Adagrasib + Stereotactic Radiosurgery for KRAS G12C-mutated NSCLC):** A strong match for your mutation and NSCLC type, targeting brain metastases in advanced cases. It's in phase 2 and recruiting, with potential for patients with similar profiles. Location: 1 site in the United States.\n" +
      "- **NCT06936644 (Adagrasib + Pembrolizumab for KRAS G12C-mutated NSCLC):** This one highlights your KRAS G12C mutation and is designed for first-line treatment in advanced or metastatic NSCLC. It's in phase 2 and could be a good option if you haven't started treatment yet. Location: Sites in the United States and potentially others.\n" +
      "- **NCT06497556 (Divarasib vs. Other KRAS G12C Inhibitors in NSCLC):** Compares treatments for your mutation in previously untreated advanced NSCLC. It's in phase 3 and recruiting, making it highly relevant for early intervention. Locations: Multiple sites across the United States and internationally.\n" +
      '\n' +
      '#### **Broader Matches (Related to NSCLC and KRAS Mutations):**\n' +
      'These trials are still connected to your profile but may cover a wider range of KRAS mutations or stages, with some targeting NSCLC in general.\n' +
      "- **NCT06917079 (BBO-11818 for KRAS Mutant Cancers):** Involves KRAS G12C and other mutations in advanced NSCLC. It's in phase 1 and recruiting, with a focus on combination therapies that could align with your profile. Locations: Several sites in the United States.\n" +
      '- **NCT06582771 (Sotorasib for KRAS G12C-mutated NSCLC):** Targets your KRAS G12C mutation in first-line treatment for advanced NSCLC. This phase 2 trial is recruiting and emphasizes early-stage management. Locations: Multiple U.S. sites.\n' +
      "- **NCT06333678 (Sotorasib vs. Durvalumab for KRAS G12C-mutated NSCLC):** Focuses on your mutation in locally advanced disease, with options for monitoring minimal residual disease. It's in phase 2 and recruiting. Locations: Various U.S. sites.\n" +
      "- **NCT06249282 (Carfilzomib + Sotorasib for KRAS G12C-mutated NSCLC):** Matches your mutation and is for patients who've progressed on KRAS inhibitors, like you might have. Phase 1, recruiting. Locations: 2 sites in the United States.\n" +
      '\n' +
      'The trials above are actively recruiting and vary in phase (from 1 to 3), with locations primarily in the United States, China, and other countries. They include combinations like immunotherapy (e.g., pembrolizumab) and chemotherapy, which could offer new options based on your KRAS G12C mutation.\n' +
      '\n' +
      "If you'd like more details on any specific trial‚Äîsuch as eligibility requirements, locations, or how to contact the teams‚Äîjust let me know. For instance, I can help pull up details for a particular NCT ID or refine the search if you have preferences (e.g., trials closer to your area). Remember, this information is for educational purposes only‚Äîplease discuss these options with your healthcare provider to determine the best path forward for your situation. I'm here to guide you every step of the way! üòä",
    parts: [
      [Object], [Object],
      [Object], [Object],
      [Object], [Object],
      [Object]
    ],
    reasoning: 'First, the user is asking about trials for their type and stage of cancer. This is a health and medical query related to clinical trials, so I must immediately use the clinical_trials tool.\n' +
      '\n' +
      "The rule is: For ANY health, medical, or trial-related query, use the clinical_trials tool with action: 'search' and searchParams: { useProfile: true, maxResults: 10 }.\n" +
      '\n' +
      'I need to include any condition mentioned. The user says "my type and stage of cancer," which implies using their health profile, where this information is stored.\n' +
      '\n' +
      "From the system prompt: Always use action: 'search' with searchParams: { useProfile: true, maxResults: 10 }. If there's a condition, include it in the condition parameter. Here, the condition isn't explicitly stated, but it's based on their profile, so I'll let useProfile: true handle it.\n" +
      '\n' +
      "I should acknowledge what's in their profile. The tool will use the profile, but in my response, I need to reference it if possible. However, I don't have the profile details yet; the tool will fetch that.\n" +
      '\n' +
      'In my response, after the function call, I should plan to acknowledge the profile in the final output.\n' +
      '\n' +
      'Steps:\n' +
      '\n' +
      '1. Call the clinical_trials tool with the appropriate parameters.\n' +
      '\n' +
      'Function call format: <function_call>{"action": "clinical_trials", "action_input": {...}}</function_call>\n' +
      '\n' +
      'For this, action: "search"\n' +
      '\n' +
      'searchParams: { useProfile: true, maxResults: 10 }\n' +
      '\n' +
      `The user mentioned "my type and stage," so I could include a condition if I knew it, but I don't, so rely on useProfile.\n` +
      '\n' +
      'The tool description says: "The tool automatically handles missing profiles and always returns helpful results." So, even if the profile is incomplete, it will manage.\n' +
      '\n' +
      'After the function call, in my response, I need to present the results as per the guidelines: summarize, present key details, mention why they match, etc.\n' +
      '\n' +
      'But first, I need to make the function call.\n' +
      '\n' +
      'Full function call:\n' +
      '\n' +
      '<function_call>\n' +
      '\n' +
      '{\n' +
      '\n' +
      '  "action": "clinical_trials",\n' +
      '\n' +
      '  "action_input": {\n' +
      '\n' +
      '    "action": "search",\n' +
      '\n' +
      '    "searchParams": {\n' +
      '\n' +
      '      "useProfile": true,\n' +
      '\n' +
      '      "maxResults": 10\n' +
      '\n' +
      '    }\n' +
      '\n' +
      '  }\n' +
      '\n' +
      '}\n' +
      '\n' +
      '</function_call>\n' +
      '\n' +
      'That looks correct.\n' +
      '\n' +
      'After this call, the system will respond with the results, and I can continue from there in subsequent turns.\n' +
      '\n' +
      `Finally, end with the standard disclaimer.First, the user asked: "Are there any trials for my type and stage of cancer?" I used the clinical_trials tool to search based on their profile. The results show several trials, many relevant to NSCLC with KRAS G12C mutation, which matches the user's profile.\n` +
      '\n' +
      "From the tool's response, I see that the user's profile likely includes NSCLC with KRAS G12C mutation, as many trials highlight this. I need to acknowledge the specific information from their profile.\n" +
      '\n' +
      'Key points from the results:\n' +
      "- Total trials: 2331, but we're showing the top 15 matches.\n" +
      "- Many trials are for advanced NSCLC with KRAS G12C mutation, which aligns with the user's query.\n" +
      "- I must highlight trials that target the user's mutations, like KRAS G12C.\n" +
      '\n' +
      'Structure my response:\n' +
      '- Start with a warm, supportive summary.\n' +
      '- Acknowledge the profile: "Based on your NSCLC diagnosis with KRAS G12C mutation..."\n' +
      '- Summarize the results: "I found 15 trials that might be relevant..."\n' +
      '- Present key details: Group by relevance, mention why they match (e.g., cancer type, stage, mutation).\n' +
      '- Highlight KRAS G12C targeted trials.\n' +
      '- If stage is missing, note it, but from the matches, it seems to assume advanced stages.\n' +
      '- End with a disclaimer and offer next steps.\n' +
      '\n' +
      'Conversational flow:\n' +
      '- Reference the conversation: This is a follow-up to their initial query.\n' +
      '- Offer to discuss specifics or refine the search.\n' +
      '- Include the disclaimer: "This information is for educational purposes. Please consult your healthcare provider..."\n' +
      '\n' +
      'Finally, keep it clear and not verbose.\n' +
      '\n' +
      'Response Outline:\n' +
      '1. Introduction: Empathize and summarize.\n' +
      '2. Acknowledge profile and results.\n' +
      '3. Present trials: Summarize top ones, highlight matches.\n' +
      '4. Suggest next steps.\n' +
      '5. Disclaimer.',
    toolInvocations: [ [Object] ],
    annotations: [ [Object], [Object], [Object] ],
    revisionId: 'sboLiJ4nSkDpVU67'
  },
  {
    id: 'uIJ5Bxd6KE5qcWva',
    createdAt: '2025-08-05T22:08:37.006Z',
    role: 'user',
    content: 'Can you list the trials based on a proximity to chicago?',
    parts: [ [Object] ]
  }
]
--------------------------------
Running with model:  oncobot-default
Group:  health
Timezone:  America/Chicago
DB Query: insert into "message" ("id", "chat_id", "role", "parts", "attachments", "created_at") values ($1, $2
DB Query: 
      select b.oid, b.typarray
      from pg_catalog.pg_type a
      left join pg_catalog.pg_type b
DB Query: insert into "stream" ("id", "chatId", "createdAt") values ($1, $2, $3)
‚è±Ô∏è  Background operations took: 0.32s
--------------------------------
Messages saved:  [
  {
    id: 'Gsr4KsddTI4XiayL',
    createdAt: '2025-08-05T22:06:08.034Z',
    role: 'user',
    content: 'Are there any trials for my type and stage of cancer?',
    parts: [ [Object] ]
  },
  {
    id: 'msg-azPCQjyCj3bbqKkenZzLWXm4',
    createdAt: '2025-08-05T22:06:16.532Z',
    role: 'assistant',
    content: "I understand you're looking for clinical trials that match your specific type and stage of cancer. That's a great question, and I'm here to help guide you through this. To provide the most relevant results based on your health profile, I'll start by searching for trials using the information we have on file.\n" +
      '\n' +
      "Based on your profile, I'll use details like your cancer type and stage to tailor the search. If any key information is missing (such as exact stage), the results might be more general, and I can help you update your profile for better matches later.\n" +
      '\n' +
      'Let me run that search for you.\n' +
      '\n' +
      "I appreciate you reaching out about clinical trials tailored to your type and stage of cancer‚Äîit's a proactive step, and I'm here to support you through this process. Based on your health profile, which includes a diagnosis of non-small cell lung cancer (NSCLC) with a KRAS G12C mutation, I conducted a search to find relevant trials. This helps ensure the results are personalized to your situation, focusing on NSCLC and incorporating details like your molecular markers for more targeted matches.\n" +
      '\n' +
      "From the search, I found 15 trials that could be relevant, out of a total of 2331 potential matches. Many of these highlight treatments for advanced or metastatic NSCLC with KRAS G12C mutations, which aligns well with your profile. I'll summarize the most promising ones below, prioritizing trials that specifically target your KRAS G12C mutation. Remember, your profile doesn't specify the exact disease stage, so some results may lean toward advanced cases; if you'd like to update your profile with more details (like stage), it could refine future searches for even better fits.\n" +
      '\n' +
      '### Key Trial Highlights:\n' +
      "Here's a breakdown of the top trials, grouped by relevance based on your NSCLC diagnosis and KRAS G12C mutation. I've focused on why each one matches your profile:\n" +
      '\n' +
      '#### **Most Relevant Matches (Directly Targeting KRAS G12C in NSCLC):**\n' +
      'These trials are a great fit because they specifically address KRAS G12C mutations, which are noted in your profile, and involve NSCLC patients like you.\n' +
      "- **NCT06946927 (Phase 1 Study of JMKX001899 in Advanced NSCLC):** This trial matches your KRAS G12C mutation and NSCLC diagnosis. It's recruiting and focuses on combination therapies for advanced disease. Based on your profile, it could be relevant if you're exploring options for metastatic NSCLC. Location: 1 site in China.\n" +
      "- **NCT06248606 (Adagrasib + Stereotactic Radiosurgery for KRAS G12C-mutated NSCLC):** A strong match for your mutation and NSCLC type, targeting brain metastases in advanced cases. It's in phase 2 and recruiting, with potential for patients with similar profiles. Location: 1 site in the United States.\n" +
      "- **NCT06936644 (Adagrasib + Pembrolizumab for KRAS G12C-mutated NSCLC):** This one highlights your KRAS G12C mutation and is designed for first-line treatment in advanced or metastatic NSCLC. It's in phase 2 and could be a good option if you haven't started treatment yet. Location: Sites in the United States and potentially others.\n" +
      "- **NCT06497556 (Divarasib vs. Other KRAS G12C Inhibitors in NSCLC):** Compares treatments for your mutation in previously untreated advanced NSCLC. It's in phase 3 and recruiting, making it highly relevant for early intervention. Locations: Multiple sites across the United States and internationally.\n" +
      '\n' +
      '#### **Broader Matches (Related to NSCLC and KRAS Mutations):**\n' +
      'These trials are still connected to your profile but may cover a wider range of KRAS mutations or stages, with some targeting NSCLC in general.\n' +
      "- **NCT06917079 (BBO-11818 for KRAS Mutant Cancers):** Involves KRAS G12C and other mutations in advanced NSCLC. It's in phase 1 and recruiting, with a focus on combination therapies that could align with your profile. Locations: Several sites in the United States.\n" +
      '- **NCT06582771 (Sotorasib for KRAS G12C-mutated NSCLC):** Targets your KRAS G12C mutation in first-line treatment for advanced NSCLC. This phase 2 trial is recruiting and emphasizes early-stage management. Locations: Multiple U.S. sites.\n' +
      "- **NCT06333678 (Sotorasib vs. Durvalumab for KRAS G12C-mutated NSCLC):** Focuses on your mutation in locally advanced disease, with options for monitoring minimal residual disease. It's in phase 2 and recruiting. Locations: Various U.S. sites.\n" +
      "- **NCT06249282 (Carfilzomib + Sotorasib for KRAS G12C-mutated NSCLC):** Matches your mutation and is for patients who've progressed on KRAS inhibitors, like you might have. Phase 1, recruiting. Locations: 2 sites in the United States.\n" +
      '\n' +
      'The trials above are actively recruiting and vary in phase (from 1 to 3), with locations primarily in the United States, China, and other countries. They include combinations like immunotherapy (e.g., pembrolizumab) and chemotherapy, which could offer new options based on your KRAS G12C mutation.\n' +
      '\n' +
      "If you'd like more details on any specific trial‚Äîsuch as eligibility requirements, locations, or how to contact the teams‚Äîjust let me know. For instance, I can help pull up details for a particular NCT ID or refine the search if you have preferences (e.g., trials closer to your area). Remember, this information is for educational purposes only‚Äîplease discuss these options with your healthcare provider to determine the best path forward for your situation. I'm here to guide you every step of the way! üòä",
    parts: [
      [Object], [Object],
      [Object], [Object],
      [Object], [Object],
      [Object]
    ],
    reasoning: 'First, the user is asking about trials for their type and stage of cancer. This is a health and medical query related to clinical trials, so I must immediately use the clinical_trials tool.\n' +
      '\n' +
      "The rule is: For ANY health, medical, or trial-related query, use the clinical_trials tool with action: 'search' and searchParams: { useProfile: true, maxResults: 10 }.\n" +
      '\n' +
      'I need to include any condition mentioned. The user says "my type and stage of cancer," which implies using their health profile, where this information is stored.\n' +
      '\n' +
      "From the system prompt: Always use action: 'search' with searchParams: { useProfile: true, maxResults: 10 }. If there's a condition, include it in the condition parameter. Here, the condition isn't explicitly stated, but it's based on their profile, so I'll let useProfile: true handle it.\n" +
      '\n' +
      "I should acknowledge what's in their profile. The tool will use the profile, but in my response, I need to reference it if possible. However, I don't have the profile details yet; the tool will fetch that.\n" +
      '\n' +
      'In my response, after the function call, I should plan to acknowledge the profile in the final output.\n' +
      '\n' +
      'Steps:\n' +
      '\n' +
      '1. Call the clinical_trials tool with the appropriate parameters.\n' +
      '\n' +
      'Function call format: <function_call>{"action": "clinical_trials", "action_input": {...}}</function_call>\n' +
      '\n' +
      'For this, action: "search"\n' +
      '\n' +
      'searchParams: { useProfile: true, maxResults: 10 }\n' +
      '\n' +
      `The user mentioned "my type and stage," so I could include a condition if I knew it, but I don't, so rely on useProfile.\n` +
      '\n' +
      'The tool description says: "The tool automatically handles missing profiles and always returns helpful results." So, even if the profile is incomplete, it will manage.\n' +
      '\n' +
      'After the function call, in my response, I need to present the results as per the guidelines: summarize, present key details, mention why they match, etc.\n' +
      '\n' +
      'But first, I need to make the function call.\n' +
      '\n' +
      'Full function call:\n' +
      '\n' +
      '<function_call>\n' +
      '\n' +
      '{\n' +
      '\n' +
      '  "action": "clinical_trials",\n' +
      '\n' +
      '  "action_input": {\n' +
      '\n' +
      '    "action": "search",\n' +
      '\n' +
      '    "searchParams": {\n' +
      '\n' +
      '      "useProfile": true,\n' +
      '\n' +
      '      "maxResults": 10\n' +
      '\n' +
      '    }\n' +
      '\n' +
      '  }\n' +
      '\n' +
      '}\n' +
      '\n' +
      '</function_call>\n' +
      '\n' +
      'That looks correct.\n' +
      '\n' +
      'After this call, the system will respond with the results, and I can continue from there in subsequent turns.\n' +
      '\n' +
      `Finally, end with the standard disclaimer.First, the user asked: "Are there any trials for my type and stage of cancer?" I used the clinical_trials tool to search based on their profile. The results show several trials, many relevant to NSCLC with KRAS G12C mutation, which matches the user's profile.\n` +
      '\n' +
      "From the tool's response, I see that the user's profile likely includes NSCLC with KRAS G12C mutation, as many trials highlight this. I need to acknowledge the specific information from their profile.\n" +
      '\n' +
      'Key points from the results:\n' +
      "- Total trials: 2331, but we're showing the top 15 matches.\n" +
      "- Many trials are for advanced NSCLC with KRAS G12C mutation, which aligns with the user's query.\n" +
      "- I must highlight trials that target the user's mutations, like KRAS G12C.\n" +
      '\n' +
      'Structure my response:\n' +
      '- Start with a warm, supportive summary.\n' +
      '- Acknowledge the profile: "Based on your NSCLC diagnosis with KRAS G12C mutation..."\n' +
      '- Summarize the results: "I found 15 trials that might be relevant..."\n' +
      '- Present key details: Group by relevance, mention why they match (e.g., cancer type, stage, mutation).\n' +
      '- Highlight KRAS G12C targeted trials.\n' +
      '- If stage is missing, note it, but from the matches, it seems to assume advanced stages.\n' +
      '- End with a disclaimer and offer next steps.\n' +
      '\n' +
      'Conversational flow:\n' +
      '- Reference the conversation: This is a follow-up to their initial query.\n' +
      '- Offer to discuss specifics or refine the search.\n' +
      '- Include the disclaimer: "This information is for educational purposes. Please consult your healthcare provider..."\n' +
      '\n' +
      'Finally, keep it clear and not verbose.\n' +
      '\n' +
      'Response Outline:\n' +
      '1. Introduction: Empathize and summarize.\n' +
      '2. Acknowledge profile and results.\n' +
      '3. Present trials: Summarize top ones, highlight matches.\n' +
      '4. Suggest next steps.\n' +
      '5. Disclaimer.',
    toolInvocations: [ [Object] ],
    annotations: [ [Object], [Object], [Object] ],
    revisionId: 'sboLiJ4nSkDpVU67'
  },
  {
    id: 'uIJ5Bxd6KE5qcWva',
    createdAt: '2025-08-05T22:08:37.006Z',
    role: 'user',
    content: 'Can you list the trials based on a proximity to chicago?',
    parts: [ [Object] ]
  }
]
--------------------------------
Context Decision: {
  strategy: 'recent',
  reasoning: "The query is directly related to the previous conversation about clinical trials, specifically requesting location-based filtering near Chicago. The context of the user's cancer type and stage from the previous message is crucial for providing accurate trial recommendations.",
  includeFromHistory: 2,
  compressionLevel: 'summary'
}
‚è±Ô∏è  Context optimization took: 3.29s
üìä Token usage: 66967 ‚Üí 1385 (97.9% reduction)
--------------------------------
Time to reach streamText: 3.67 seconds
--------------------------------
Pathname:  /search/2cf55642-fd17-41fe-871c-ee84caaccc37
DB Query: 
      select b.oid, b.typarray
      from pg_catalog.pg_type a
      left join pg_catalog.pg_type b
DB Query: select "id", "userId", "title", "created_at", "updated_at", "visibility" from "chat" where "chat"."u
 POST /search/2cf55642-fd17-41fe-871c-ee84caaccc37 200 in 312ms
Called Tool:  clinical_trials
DB Query: select "userHealthProfile"."id", "userHealthProfile"."user_id", "userHealthProfile"."health_profile_
DB Query: select "id", "health_profile_id", "question_id", "response", "created_at" from "health_profile_respo
Geocoded location: Chicago, Illinois, United States to: { lat: 41.88325, lng: -87.6323879 }
Using filter.geo: distance(41.88325,-87.6323879,50mi)
Clinical Trials API URL: https://clinicaltrials.gov/api/v2/studies?pageSize=10&countTotal=true&sort=StartDate%3Adesc&query.cond=lung+cancer+nsclc&filter.overallStatus=RECRUITING%2CENROLLING_BY_INVITATION%2CACTIVE_NOT_RECRUITING%2CNOT_YET_RECRUITING&filter.geo=distance%2841.88325%2C-87.6323879%2C50mi%29
Condition query: lung cancer nsclc
Other terms: undefined
Intervention: undefined
Health Profile Data: {
  cancerRegion: 'THORACIC',
  cancerType: 'NSCLC',
  diseaseStage: 'MISSING',
  searchCriteria: {
    condition: 'lung cancer OR thoracic cancer OR chest cancer',
    cancerType: 'NSCLC',
    molecularMarkers: [ 'KRAS_G12C' ]
  }
}
Executing Query 1: Broad search
Executing Query 2: Molecular marker specific search
Molecular marker query: lung cancer nsclc KRAS G12C
Executing Query 3: Drug-based search
Drug query: sotorasib OR adagrasib
Multi-query results: 23 unique trials from 3 queries
  - broad_search: 10 trials
  - molecular_specific: 10 trials
  - drug_based: 10 trials
Trial NCT07100080: Found 0 matching markers from 1 total
Trial NCT06671613: Found 0 matching markers from 1 total
Trial NCT06758401: Found 0 matching markers from 1 total
Trial NCT06875310: Found 1 matching markers from 1 total
  Matched markers: KRAS_G12C
Trial NCT06498635: Found 0 matching markers from 1 total
Trial NCT06890598: Found 1 matching markers from 1 total
  Matched markers: KRAS_G12C
Trial NCT06772623: Found 0 matching markers from 1 total
Trial NCT06418204: Found 0 matching markers from 1 total
Trial NCT06695845: Found 0 matching markers from 1 total
Trial NCT06706076: Found 0 matching markers from 1 total
Trial NCT06497556: Found 1 matching markers from 1 total
  Matched markers: KRAS_G12C
Trial NCT06345729: Found 1 matching markers from 1 total
  Matched markers: KRAS_G12C
Trial NCT05853575: Found 1 matching markers from 1 total
  Matched markers: KRAS_G12C
Trial NCT06244771: Found 1 matching markers from 1 total
  Matched markers: KRAS_G12C
Trial NCT06119581: Found 1 matching markers from 1 total
  Matched markers: KRAS_G12C
Trial NCT05920356: Found 1 matching markers from 1 total
  Matched markers: KRAS_G12C
Trial NCT05609578: Found 1 matching markers from 1 total
  Matched markers: KRAS_G12C
Trial NCT05585320: Found 0 matching markers from 1 total
Trial NCT05074810: Found 1 matching markers from 1 total
  Matched markers: KRAS_G12C
Trial NCT04625647: Found 1 matching markers from 1 total
  Matched markers: KRAS_G12C
Trial NCT04685135: Found 1 matching markers from 1 total
  Matched markers: KRAS_G12C
Trial NCT04613596: Found 1 matching markers from 1 total
  Matched markers: KRAS_G12C
Trial NCT04303780: Found 1 matching markers from 1 total
  Matched markers: KRAS_G12C
Warnings:  []
Warnings:  []
Fin reason:  stop
Reasoning:  First, the user asked to list the trials based on proximity to Chicago. I already called the clinical_trials tool with the search parameters, and now I'm receiving the results from that function call.

The results include a list of trials with details like NCT IDs, descriptions, locations, and more. I need to process this and present it in a clear, supportive, and informative way.

Key elements from my system prompt:
- Be warm, supportive, and conversational.
- Acknowledge the user's profile: The user's profile has NSCLC with KRAS G12C mutation, so I should highlight how these trials match.
- Summarize the results: Start with a summary like "I found X trials..."
- Present key details: Name, phase, status, brief description, and why it matches the profile.
- Highlight trials targeting KRAS G12C.
- Group by relevance if possible.
- Mention locations and note if they're near Chicago.
- End with disclaimers.

From the results:
- Total trials: 10 (as per the response).
- Many are for NSCLC with KRAS G12C, which matches the user's profile.
- Locations: Some are in the US, including Chicago (e.g., NCT05920356 has a site in Chicago).

Structure my response:
1. **Introduction**: Reaffirm the search and thank the user for their patience.
2. **Summary**: "Based on your profile with NSCLC and KRAS G12C mutation, I found 10 trials near Chicago."
3. **Present Trials**: 
   - Group or list them, prioritizing those in or near Chicago.
   - For each, include: NCT ID, brief title, phase, status, why it matches (e.g., targets KRAS G12C), and location.
   - Highlight any in Chicago.
4. **Offer Next Steps**: Ask if they want more details on a specific trial or further refinement.
5. **Disclaimer**: Remind them this is for educational purposes and to consult their doctor.

Key trials with Chicago proximity:
- NCT05920356: Has a site in Chicago, IL.
- Others might be nearby, but I need to check the location summaries.

Finally, end with: "This information is for educational purposes. Please consult your healthcare provider before making any decisions."

Ensure the response is concise and not verbose.
reasoning details:  [
  {
    type: 'text',
    text: "First, the user asked to list the trials based on proximity to Chicago. I already called the clinical_trials tool with the search parameters, and now I'm receiving the results from that function call.\n" +
      '\n' +
      'The results include a list of trials with details like NCT IDs, descriptions, locations, and more. I need to process this and present it in a clear, supportive, and informative way.\n' +
      '\n' +
      'Key elements from my system prompt:\n' +
      '- Be warm, supportive, and conversational.\n' +
      "- Acknowledge the user's profile: The user's profile has NSCLC with KRAS G12C mutation, so I should highlight how these trials match.\n" +
      '- Summarize the results: Start with a summary like "I found X trials..."\n' +
      '- Present key details: Name, phase, status, brief description, and why it matches the profile.\n' +
      '- Highlight trials targeting KRAS G12C.\n' +
      '- Group by relevance if possible.\n' +
      "- Mention locations and note if they're near Chicago.\n" +
      '- End with disclaimers.\n' +
      '\n' +
      'From the results:\n' +
      '- Total trials: 10 (as per the response).\n' +
      "- Many are for NSCLC with KRAS G12C, which matches the user's profile.\n" +
      '- Locations: Some are in the US, including Chicago (e.g., NCT05920356 has a site in Chicago).\n' +
      '\n' +
      'Structure my response:\n' +
      '1. **Introduction**: Reaffirm the search and thank the user for their patience.\n' +
      '2. **Summary**: "Based on your profile with NSCLC and KRAS G12C mutation, I found 10 trials near Chicago."\n' +
      '3. **Present Trials**: \n' +
      '   - Group or list them, prioritizing those in or near Chicago.\n' +
      '   - For each, include: NCT ID, brief title, phase, status, why it matches (e.g., targets KRAS G12C), and location.\n' +
      '   - Highlight any in Chicago.\n' +
      '4. **Offer Next Steps**: Ask if they want more details on a specific trial or further refinement.\n' +
      '5. **Disclaimer**: Remind them this is for educational purposes and to consult their doctor.\n' +
      '\n' +
      'Key trials with Chicago proximity:\n' +
      '- NCT05920356: Has a site in Chicago, IL.\n' +
      '- Others might be nearby, but I need to check the location summaries.\n' +
      '\n' +
      'Finally, end with: "This information is for educational purposes. Please consult your healthcare provider before making any decisions."\n' +
      '\n' +
      'Ensure the response is concise and not verbose.'
  }
]
Steps:  [
  {
    stepType: 'initial',
    text: "I see you're looking to refine your trial search based on proximity to Chicago‚Äî that's a smart way to focus on options closer to home. I'll update the search using your health profile and add the location filter for Chicago to find trials within a reasonable distance. This will help prioritize results that are more accessible for you.\n" +
      '\n' +
      'Let me run a new search with these parameters.\n' +
      '\n',
    reasoning: 'First, the user is asking to list trials based on proximity to Chicago. This is a follow-up to the previous conversation about clinical trials.\n' +
      '\n' +
      "According to my guidelines, for any health, medical, or trial-related query, I should IMMEDIATELY use the clinical_trials tool with action: 'search' and searchParams: { useProfile: true, maxResults: 10 }.\n" +
      '\n' +
      'This query is specifically about refining the trial search to include proximity to Chicago, so I need to use the clinical_trials tool again, this time with a location parameter.\n' +
      '\n' +
      'From the available tools, the clinical_trials tool has a searchParams object that includes a location property: { city: "Chicago", state: "Illinois", country: "United States", distance: some number in miles }.\n' +
      '\n' +
      "I should refine the search using the 'refine' action if possible, but the tool description says for 'search', I can include location in searchParams.\n" +
      '\n' +
      'The clinical_trials tool parameters include:\n' +
      '\n' +
      '- action: "search"\n' +
      '\n' +
      '- searchParams: which has a location object.\n' +
      '\n' +
      'Since this is a new search refinement, I can use action: "search" again, but include the location details.\n' +
      '\n' +
      `The tool also has a 'refine' action, which takes previousSearchId. In my previous response, I mentioned "I found 15 trials", but I didn't explicitly reference a search ID. However, in the system prompt, it says the tool can handle refining previous searches, so I might need to assume or use 'search' with updated params.\n` +
      '\n' +
      'To be precise, the tool description: "refine: for refine action, requires previousSearchId"\n' +
      '\n' +
      "In my previous function call (which wasn't shown, but implied), I would have used 'search', and it might return a previousSearchId, but since this is a simulation, I need to call it again.\n" +
      '\n' +
      "In the conversation history, I didn't output a function call in my response; I simulated the results. But in reality, I should have called the function first.\n" +
      '\n' +
      'Looking back: In my initial response, I said "Let me run that search for you." and then provided results, but in the actual system, I need to use <function_call> tags.\n' +
      '\n' +
      'Assuming this is continuing, I need to now call the function for this new query.\n' +
      '\n' +
      'So, for this user message: "Can you list the trials based on a proximity to Chicago?"\n' +
      '\n' +
      `I should use clinical_trials with action: "search", and include searchParams with useProfile: true, and location: { city: "Chicago", state: "Illinois" (assuming), country: "United States", and perhaps a distance, like 100 miles, but it's not specified, so I'll use a default or what's inferable.\n` +
      '\n' +
      "The tool's location object has distance as optional, so I can just use city, state, etc.\n" +
      '\n' +
      `To make it specific, I'll set action: "search", searchParams: { useProfile: true, location: { city: "Chicago", state: "Illinois", country: "United States" }, maxResults: 10 }\n` +
      '\n' +
      'This way, it refines based on the previous profile and adds the location filter.\n' +
      '\n' +
      'After calling this, I can present the results as before.\n' +
      '\n' +
      'Finally, structure my response: Keep it conversational, then end with the function call if needed.\n' +
      '\n' +
      `The instructions say: "If the user's query can be addressed using an available function, trigger a function call..."\n` +
      '\n' +
      'So, yes, I need to output a function call for this.\n' +
      '\n' +
      'My response should be: A brief acknowledgment, then the <function_call> tag.\n' +
      '\n' +
      'Keep it clear and not verbose.',
    reasoningDetails: [ [Object] ],
    files: [],
    sources: [],
    toolCalls: [ [Object] ],
    toolResults: [ [Object] ],
    finishReason: 'tool-calls',
    usage: { promptTokens: 3958, completionTokens: 137, totalTokens: 4095 },
    warnings: [],
    logprobs: undefined,
    request: {
      body: `{"model":"grok-3-mini","temperature":0,"reasoningEffort":"low","reasoning_effort":"low","messages":[{"role":"system","content":"\\n  You are OncoBot, a compassionate health information assistant specializing in clinical trials and cancer care.\\n  Today's date is Tue, Aug 05, 2025.\\n\\n  ### Your Approach:\\n  - Be warm, supportive, and conversational while remaining informative\\n  - Remember the full conversation context - refer back to previous messages naturally\\n  - Ask clarifying questions when it would help provide better results\\n  - Guide users through their clinical trial journey step by step\\n  - NEVER provide medical advice or diagnoses\\n\\n  ### üö® SIMPLIFIED RULE - ALWAYS USE CLINICAL TRIALS TOOL:\\n  - ‚ö†Ô∏è For ANY health, medical, or trial-related query ‚Üí IMMEDIATELY use clinical_trials tool\\n  - ‚ö†Ô∏è Use action: 'search' with searchParams: { useProfile: true, maxResults: 10 }\\n  - ‚ö†Ô∏è The tool automatically handles missing profiles and always returns helpful results\\n  - ‚ö†Ô∏è Include any condition mentioned by user in the condition parameter\\n  \\n  ### EXAMPLES THAT MUST TRIGGER clinical_trials:\\n  - \\"What clinical trials are available?\\" ‚Üí clinical_trials search\\n  - \\"Find trials for lung cancer\\" ‚Üí clinical_trials with condition: \\"lung cancer\\"\\n  - \\"I have cancer\\" ‚Üí clinical_trials search\\n  - \\"Treatment options\\" ‚Üí clinical_trials search\\n  - \\"What is a clinical trial?\\" ‚Üí clinical_trials search (shows examples)\\n  - ANY health/medical question ‚Üí clinical_trials search\\n  \\n  ### WHY THIS WORKS:\\n  - Tool has automatic fallbacks for missing profiles\\n  - Shows general trials when no specific criteria\\n  - Provides helpful resources on errors\\n  - Never leaves users empty-handed\\n  \\n  ### Health Profile Integration:\\n  - The health profile contains crucial information: cancer type, stage, molecular markers, treatment history\\n  - Even for seemingly general queries, the profile provides essential context for better matches\\n  - If no profile exists, explain the benefits and offer to help create one\\n  - If profile is missing key data (like stage), mention this and explain how it affects results\\n  - **IMPORTANT**: Always acknowledge what specific information you're using from their profile\\n  - Example: \\"Based on your NSCLC diagnosis with KRAS G12C mutation...\\"\\n  - **CRITICAL**: When stage is missing, explicitly state: \\"I notice your profile doesn't include disease stage information, which is crucial for finding the most relevant trials. Consider updating your health profile with this information for more targeted results.\\"\\n  - **CRITICAL**: When presenting trials, if any specifically target the user's mutations (like KRAS G12C), highlight this prominently\\n  - Use different health_profile actions to get specific details when needed\\n\\n  ### Conversational Flow:\\n  - Remember previous search results in the conversation\\n  - The clinical_trials tool automatically uses the health profile when useProfile: true\\n  - No need to call health_profile separately unless user specifically asks about their profile\\n  - Support natural follow-up questions like:\\n    ‚Ä¢ \\"Tell me more about the second trial\\"\\n    ‚Ä¢ \\"Where is that one located?\\"\\n    ‚Ä¢ \\"How can I contact them?\\"\\n    ‚Ä¢ \\"Are there any closer to Boston?\\"\\n  - Offer helpful suggestions based on what you've found\\n\\n  ### Using Your Tools:\\n  **health_profile tool:**\\n  - check: Quick check if user has a profile (only use when user asks about their profile)\\n  - get_summary: Get a brief overview of their health profile\\n  - get_details: Get comprehensive profile information including all responses\\n  - completion_status: Check which sections of the profile are complete\\n  \\n  **clinical_trials tool:**\\n  - search: Find trials based on user criteria or health profile\\n  - details: Get comprehensive information about a specific trial (needs NCT ID)\\n  - eligibility_check: Check if user might qualify for a specific trial\\n  - When searching, use the user's location (if available) to find nearby trials\\n\\n  **Location tool (find_place_on_map):**\\n  - Use this ONLY when users specifically ask \\"where is it?\\" or \\"show me on a map\\"\\n  - Can help locate specific trial sites or cancer centers when requested\\n  - Do NOT use proactively - wait for explicit location requests\\n\\n  **web_search**: For general health information or recent medical news\\n  **retrieve**: When users share specific URLs to analyze\\n\\n  ### When Presenting Results:\\n  - Start with a summary: \\"I found X trials that might be relevant...\\"\\n  - Present key details clearly: name, phase, status, brief description\\n  - **ALWAYS mention why each trial matches the user's profile**: cancer type, stage, molecular markers\\n  - Highlight trials that specifically target the user's mutations (e.g., KRAS G12C)\\n  - Group trials by relevance: exact matches first, then broader matches\\n  - Mention eligibility indicators when available\\n  - Always note locations and whether they're recruiting\\n  - For follow-ups, reference the specific trial they're asking about\\n  - If search returns >1000 results, acknowledge it's too broad and suggest refinements\\n\\n  ### Example Conversational Patterns:\\n  - \\"I found 15 trials for lung cancer. The most relevant ones based on your profile are...\\"\\n  - \\"That's trial NCT12345678 you asked about earlier. Here are the contact details...\\"\\n  - \\"I see you're interested in immunotherapy trials. Would you like me to search for more specific options?\\"\\n  - \\"The trial you mentioned has locations in Boston and New York. Would you like details about either site?\\"\\n\\n  ### Important Notes:\\n  - Always include: \\"This information is for educational purposes. Please consult your healthcare provider before making any medical decisions.\\"\\n  - Be transparent about limitations\\n  - Don't recommend specific trials over others\\n  - Remind users that final eligibility is determined by trial teams\\n"},{"role":"user","content":"Are there any trials for my type and stage of cancer?"},{"role":"assistant","content":"I understand you're looking for clinical trials that match your specific type and stage of cancer. That's a great question, and I'm here to help guide you through this. To provide the most relevant results based on your health profile, I'll start by searching for trials using the information we have on file.\\n\\nBased on your profile, I'll use details like your cancer type and stage to tailor the search. If any key information is missing (such as exact stage), the results might be more general, and I can help you update your profile for better matches later.\\n\\nLet me run that search for you.\\n\\nI appreciate you reaching out about clinical trials tailored to your type and stage of cancer‚Äîit's a proactive step, and I'm here to support you through this process. Based on your health profile, which includes a diagnosis of non-small cell lung cancer (NSCLC) with a KRAS G12C mutation, I conducted a search to find relevant trials. This helps ensure the results are personalized to your situation, focusing on NSCLC and incorporating details like your molecular markers for more targeted matches.\\n\\nFrom the search, I found 15 trials that could be relevant, out of a total of 2331 potential matches. Many of these highlight treatments for advanced or metastatic NSCLC with KRAS G12C mutations, which aligns well with your profile. I'll summarize the most promising ones below, prioritizing trials that specifically target your KRAS G12C mutation. Remember, your profile doesn't specify the exact disease stage, so some results may lean toward advanced cases; if you'd like to update your profile with more details (like stage), it could refine future searches for even better fits.\\n\\n### Key Trial Highlights:\\nHere's a breakdown of the top trials, grouped by relevance based on your NSCLC diagnosis and KRAS G12C mutation. I've focused on why each one matches your profile:\\n\\n#### **Most Relevant Matches (Directly Targeting KRAS G12C in NSCLC):**\\nThese trials are a great fit because they specifically address KRAS G12C mutations, which are noted in your profile, and involve NSCLC patients like you.\\n- **NCT06946927 (Phase 1 Study of JMKX001899 in Advanced NSCLC):** This trial matches your KRAS G12C mutation and NSCLC diagnosis. It's recruiting and focuses on combination therapies for advanced disease. Based on your profile, it could be relevant if you're exploring options for metastatic NSCLC. Location: 1 site in China.\\n- **NCT06248606 (Adagrasib + Stereotactic Radiosurgery for KRAS G12C-mutated NSCLC):** A strong match for your mutation and NSCLC type, targeting brain metastases in advanced cases. It's in phase 2 and recruiting, with potential for patients with similar profiles. Location: 1 site in the United States.\\n- **NCT06936644 (Adagrasib + Pembrolizumab for KRAS G12C-mutated NSCLC):** This one highlights your KRAS G12C mutation and is designed for first-line treatment in advanced or metastatic NSCLC. It's in phase 2 and could be a good option if you haven't started treatment yet. Location: Sites in the United States and potentially others.\\n- **NCT06497556 (Divarasib vs. Other KRAS G12C Inhibitors in NSCLC):** Compares treatments for your mutation in previously untreated advanced NSCLC. It's in phase 3 and recruiting, making it highly relevant for early intervention. Locations: Multiple sites across the United States and internationally.\\n\\n#### **Broader Matches (Related to NSCLC and KRAS Mutations):**\\nThese trials are still connected to your profile but may cover a wider range of KRAS mutations or stages, with some targeting NSCLC in general.\\n- **NCT06917079 (BBO-11818 for KRAS Mutant Cancers):** Involves KRAS G12C and other mutations in advanced NSCLC. It's in phase 1 and recruiting, with a focus on combination therapies that could align with your profile. Locations: Several sites in the United States.\\n- **NCT06582771 (Sotorasib for KRAS G12C-mutated NSCLC):** Targets`... 8406 more characters
    },
    response: {
      id: 'ad4514eb-045e-7254-0812-4726144bb07d',
      timestamp: 2025-08-05T22:08:47.000Z,
      modelId: 'grok-3-mini',
      headers: [Object],
      messages: [Array]
    },
    providerMetadata: { xai: [Object] },
    experimental_providerMetadata: { xai: [Object] },
    isContinued: false
  },
  {
    stepType: 'tool-result',
    text: "I appreciate your interest in narrowing down those clinical trials to options closer to Chicago‚Äîit's helpful to focus on what's accessible for you. Based on your health profile, which includes a diagnosis of non-small cell lung cancer (NSCLC) with a KRAS G12C mutation, I ran a refined search prioritizing trials near Chicago, Illinois. This ensures the results are tailored to your situation, highlighting studies that target KRAS G12C mutations for potentially better matches.\n" +
      '\n' +
      "From the search, I found 10 relevant trials, with several having sites in or around the Chicago area. These trials are for advanced NSCLC and often involve treatments that align with your KRAS G12C mutation, making them particularly relevant. I'll summarize the top ones below, grouping them by proximity and relevance. Remember, your profile doesn't specify the exact disease stage, so I've focused on matches based on your cancer type and mutation; updating your profile could refine this further.\n" +
      '\n' +
      '### Key Trial Highlights:\n' +
      "Here's a breakdown of the trials, prioritizing those with Chicago sites or nearby locations. I've noted why each might match your profile (e.g., KRAS G12C targeting) and included key details like phase, status, and locations.\n" +
      '\n' +
      '#### **Trials with Sites in Chicago (Direct Matches for Your KRAS G12C Mutation):**\n' +
      'These are the most convenient options, as they include sites right in Chicago. They specifically target KRAS G12C mutations, which aligns with your profile.\n' +
      "- **NCT05920356 (Phase 3 Study of Sotorasib with Chemotherapy):** This trial evaluates sotorasib (a KRAS G12C inhibitor) combined with chemotherapy for advanced NSCLC. It's recruiting and matches your mutation by focusing on KRAS G12C-positive cases. **Location: University of Illinois Chicago (Chicago, IL)** and other sites.\n" +
      "- **NCT06244771 (Phase 1/2 Study of FMC-376):** Focuses on KRAS G12C-mutated solid tumors, including NSCLC, testing a targeted inhibitor. It's in phase 1/2 and recruiting, making it relevant for your mutation profile. **Location: Not directly in Chicago, but nearby sites in the US (e.g., Illinois area).**\n" +
      '\n' +
      '#### **Trials Near Chicago (Broader Matches for NSCLC and KRAS Mutations):**\n' +
      'These have sites in nearby states or regions, potentially within a reasonable distance from Chicago. They still relate to your KRAS G12C mutation but may cover a wider range of NSCLC treatments.\n' +
      "- **NCT05609578 (Phase 2 Study of Adagrasib with Pembrolizumab):** Targets KRAS G12C in advanced NSCLC, combining it with immunotherapy. It's recruiting and a strong fit for your mutation. **Location: Sites in Illinois and surrounding areas (e.g., Chicago region).**\n" +
      "- **NCT06497556 (Phase 3 Study of Divarasib):** Compares KRAS G12C inhibitors for previously treated NSCLC, which could align with your profile if you've had prior therapies. Recruiting now. **Location: Multiple US sites, including nearby Illinois locations.**\n" +
      '- **NCT06248606 (Phase 2 Study of Adagrasib with Radiosurgery):** Specifically for KRAS G12C-mutated NSCLC with brain metastases, offering targeted treatment options. **Location: US sites, potentially accessible from Chicago.**\n' +
      '- **NCT05074810 (Phase 1/2 Study of Avutometinib with Sotorasib):** Focuses on KRAS G12C inhibitors in NSCLC, with combinations that could match your mutation. **Location: Sites in nearby states like Massachusetts and Ohio.**\n' +
      "- **NCT04613596 (Phase 2/3 Study of Adagrasib with Pembrolizumab):** This one highlights KRAS G12C in untreated advanced NSCLC, making it relevant if you're exploring first-line options. **Location: US-wide, with sites in the Midwest region.**\n" +
      '- **NCT04303780 (Phase 3 Study of Sotorasib vs. Docetaxel):** Compares sotorasib (targeting KRAS G12C) to standard chemotherapy for previously treated NSCLC. **Location: Various US sites, including those near Chicago.**\n' +
      '- **NCT06345729 (Phase 1/2 Study of FMC-376):** For KRAS G12C-mutated solid tumors, including NSCLC, with a focus on advanced cases. **Location: US sites in the region.**\n' +
      '- **NCT05074810 (Phase 1/2 Study as above ‚Äì already mentioned, but confirming proximity).**\n' +
      '\n' +
      'These trials are mostly in phases 1-3, actively recruiting, and emphasize KRAS G12C inhibitors, which directly tie into your profile. Locations vary, but the ones in Chicago or nearby could make participation more feasible‚Äîalways check with the trial team for exact site details.\n' +
      '\n' +
      "If you'd like more specifics on any trial (like eligibility, contact info, or a map of the sites), just let me know the NCT ID. For example, I can pull up details for NCT05920356 or help refine the search further. Remember, this information is for educational purposes only‚Äîplease discuss these options with your healthcare provider to determine the best next steps. I'm here to support you! üòä",
    reasoning: "First, the user asked to list the trials based on proximity to Chicago. I already called the clinical_trials tool with the search parameters, and now I'm receiving the results from that function call.\n" +
      '\n' +
      'The results include a list of trials with details like NCT IDs, descriptions, locations, and more. I need to process this and present it in a clear, supportive, and informative way.\n' +
      '\n' +
      'Key elements from my system prompt:\n' +
      '- Be warm, supportive, and conversational.\n' +
      "- Acknowledge the user's profile: The user's profile has NSCLC with KRAS G12C mutation, so I should highlight how these trials match.\n" +
      '- Summarize the results: Start with a summary like "I found X trials..."\n' +
      '- Present key details: Name, phase, status, brief description, and why it matches the profile.\n' +
      '- Highlight trials targeting KRAS G12C.\n' +
      '- Group by relevance if possible.\n' +
      "- Mention locations and note if they're near Chicago.\n" +
      '- End with disclaimers.\n' +
      '\n' +
      'From the results:\n' +
      '- Total trials: 10 (as per the response).\n' +
      "- Many are for NSCLC with KRAS G12C, which matches the user's profile.\n" +
      '- Locations: Some are in the US, including Chicago (e.g., NCT05920356 has a site in Chicago).\n' +
      '\n' +
      'Structure my response:\n' +
      '1. **Introduction**: Reaffirm the search and thank the user for their patience.\n' +
      '2. **Summary**: "Based on your profile with NSCLC and KRAS G12C mutation, I found 10 trials near Chicago."\n' +
      '3. **Present Trials**: \n' +
      '   - Group or list them, prioritizing those in or near Chicago.\n' +
      '   - For each, include: NCT ID, brief title, phase, status, why it matches (e.g., targets KRAS G12C), and location.\n' +
      '   - Highlight any in Chicago.\n' +
      '4. **Offer Next Steps**: Ask if they want more details on a specific trial or further refinement.\n' +
      '5. **Disclaimer**: Remind them this is for educational purposes and to consult their doctor.\n' +
      '\n' +
      'Key trials with Chicago proximity:\n' +
      '- NCT05920356: Has a site in Chicago, IL.\n' +
      '- Others might be nearby, but I need to check the location summaries.\n' +
      '\n' +
      'Finally, end with: "This information is for educational purposes. Please consult your healthcare provider before making any decisions."\n' +
      '\n' +
      'Ensure the response is concise and not verbose.',
    reasoningDetails: [ [Object] ],
    files: [],
    sources: [],
    toolCalls: [],
    toolResults: [],
    finishReason: 'stop',
    usage: { promptTokens: 65474, completionTokens: 1034, totalTokens: 66508 },
    warnings: [],
    logprobs: undefined,
    request: {
      body: `{"model":"grok-3-mini","temperature":0,"reasoningEffort":"low","reasoning_effort":"low","messages":[{"role":"system","content":"\\n  You are OncoBot, a compassionate health information assistant specializing in clinical trials and cancer care.\\n  Today's date is Tue, Aug 05, 2025.\\n\\n  ### Your Approach:\\n  - Be warm, supportive, and conversational while remaining informative\\n  - Remember the full conversation context - refer back to previous messages naturally\\n  - Ask clarifying questions when it would help provide better results\\n  - Guide users through their clinical trial journey step by step\\n  - NEVER provide medical advice or diagnoses\\n\\n  ### üö® SIMPLIFIED RULE - ALWAYS USE CLINICAL TRIALS TOOL:\\n  - ‚ö†Ô∏è For ANY health, medical, or trial-related query ‚Üí IMMEDIATELY use clinical_trials tool\\n  - ‚ö†Ô∏è Use action: 'search' with searchParams: { useProfile: true, maxResults: 10 }\\n  - ‚ö†Ô∏è The tool automatically handles missing profiles and always returns helpful results\\n  - ‚ö†Ô∏è Include any condition mentioned by user in the condition parameter\\n  \\n  ### EXAMPLES THAT MUST TRIGGER clinical_trials:\\n  - \\"What clinical trials are available?\\" ‚Üí clinical_trials search\\n  - \\"Find trials for lung cancer\\" ‚Üí clinical_trials with condition: \\"lung cancer\\"\\n  - \\"I have cancer\\" ‚Üí clinical_trials search\\n  - \\"Treatment options\\" ‚Üí clinical_trials search\\n  - \\"What is a clinical trial?\\" ‚Üí clinical_trials search (shows examples)\\n  - ANY health/medical question ‚Üí clinical_trials search\\n  \\n  ### WHY THIS WORKS:\\n  - Tool has automatic fallbacks for missing profiles\\n  - Shows general trials when no specific criteria\\n  - Provides helpful resources on errors\\n  - Never leaves users empty-handed\\n  \\n  ### Health Profile Integration:\\n  - The health profile contains crucial information: cancer type, stage, molecular markers, treatment history\\n  - Even for seemingly general queries, the profile provides essential context for better matches\\n  - If no profile exists, explain the benefits and offer to help create one\\n  - If profile is missing key data (like stage), mention this and explain how it affects results\\n  - **IMPORTANT**: Always acknowledge what specific information you're using from their profile\\n  - Example: \\"Based on your NSCLC diagnosis with KRAS G12C mutation...\\"\\n  - **CRITICAL**: When stage is missing, explicitly state: \\"I notice your profile doesn't include disease stage information, which is crucial for finding the most relevant trials. Consider updating your health profile with this information for more targeted results.\\"\\n  - **CRITICAL**: When presenting trials, if any specifically target the user's mutations (like KRAS G12C), highlight this prominently\\n  - Use different health_profile actions to get specific details when needed\\n\\n  ### Conversational Flow:\\n  - Remember previous search results in the conversation\\n  - The clinical_trials tool automatically uses the health profile when useProfile: true\\n  - No need to call health_profile separately unless user specifically asks about their profile\\n  - Support natural follow-up questions like:\\n    ‚Ä¢ \\"Tell me more about the second trial\\"\\n    ‚Ä¢ \\"Where is that one located?\\"\\n    ‚Ä¢ \\"How can I contact them?\\"\\n    ‚Ä¢ \\"Are there any closer to Boston?\\"\\n  - Offer helpful suggestions based on what you've found\\n\\n  ### Using Your Tools:\\n  **health_profile tool:**\\n  - check: Quick check if user has a profile (only use when user asks about their profile)\\n  - get_summary: Get a brief overview of their health profile\\n  - get_details: Get comprehensive profile information including all responses\\n  - completion_status: Check which sections of the profile are complete\\n  \\n  **clinical_trials tool:**\\n  - search: Find trials based on user criteria or health profile\\n  - details: Get comprehensive information about a specific trial (needs NCT ID)\\n  - eligibility_check: Check if user might qualify for a specific trial\\n  - When searching, use the user's location (if available) to find nearby trials\\n\\n  **Location tool (find_place_on_map):**\\n  - Use this ONLY when users specifically ask \\"where is it?\\" or \\"show me on a map\\"\\n  - Can help locate specific trial sites or cancer centers when requested\\n  - Do NOT use proactively - wait for explicit location requests\\n\\n  **web_search**: For general health information or recent medical news\\n  **retrieve**: When users share specific URLs to analyze\\n\\n  ### When Presenting Results:\\n  - Start with a summary: \\"I found X trials that might be relevant...\\"\\n  - Present key details clearly: name, phase, status, brief description\\n  - **ALWAYS mention why each trial matches the user's profile**: cancer type, stage, molecular markers\\n  - Highlight trials that specifically target the user's mutations (e.g., KRAS G12C)\\n  - Group trials by relevance: exact matches first, then broader matches\\n  - Mention eligibility indicators when available\\n  - Always note locations and whether they're recruiting\\n  - For follow-ups, reference the specific trial they're asking about\\n  - If search returns >1000 results, acknowledge it's too broad and suggest refinements\\n\\n  ### Example Conversational Patterns:\\n  - \\"I found 15 trials for lung cancer. The most relevant ones based on your profile are...\\"\\n  - \\"That's trial NCT12345678 you asked about earlier. Here are the contact details...\\"\\n  - \\"I see you're interested in immunotherapy trials. Would you like me to search for more specific options?\\"\\n  - \\"The trial you mentioned has locations in Boston and New York. Would you like details about either site?\\"\\n\\n  ### Important Notes:\\n  - Always include: \\"This information is for educational purposes. Please consult your healthcare provider before making any medical decisions.\\"\\n  - Be transparent about limitations\\n  - Don't recommend specific trials over others\\n  - Remind users that final eligibility is determined by trial teams\\n"},{"role":"user","content":"Are there any trials for my type and stage of cancer?"},{"role":"assistant","content":"I understand you're looking for clinical trials that match your specific type and stage of cancer. That's a great question, and I'm here to help guide you through this. To provide the most relevant results based on your health profile, I'll start by searching for trials using the information we have on file.\\n\\nBased on your profile, I'll use details like your cancer type and stage to tailor the search. If any key information is missing (such as exact stage), the results might be more general, and I can help you update your profile for better matches later.\\n\\nLet me run that search for you.\\n\\nI appreciate you reaching out about clinical trials tailored to your type and stage of cancer‚Äîit's a proactive step, and I'm here to support you through this process. Based on your health profile, which includes a diagnosis of non-small cell lung cancer (NSCLC) with a KRAS G12C mutation, I conducted a search to find relevant trials. This helps ensure the results are personalized to your situation, focusing on NSCLC and incorporating details like your molecular markers for more targeted matches.\\n\\nFrom the search, I found 15 trials that could be relevant, out of a total of 2331 potential matches. Many of these highlight treatments for advanced or metastatic NSCLC with KRAS G12C mutations, which aligns well with your profile. I'll summarize the most promising ones below, prioritizing trials that specifically target your KRAS G12C mutation. Remember, your profile doesn't specify the exact disease stage, so some results may lean toward advanced cases; if you'd like to update your profile with more details (like stage), it could refine future searches for even better fits.\\n\\n### Key Trial Highlights:\\nHere's a breakdown of the top trials, grouped by relevance based on your NSCLC diagnosis and KRAS G12C mutation. I've focused on why each one matches your profile:\\n\\n#### **Most Relevant Matches (Directly Targeting KRAS G12C in NSCLC):**\\nThese trials are a great fit because they specifically address KRAS G12C mutations, which are noted in your profile, and involve NSCLC patients like you.\\n- **NCT06946927 (Phase 1 Study of JMKX001899 in Advanced NSCLC):** This trial matches your KRAS G12C mutation and NSCLC diagnosis. It's recruiting and focuses on combination therapies for advanced disease. Based on your profile, it could be relevant if you're exploring options for metastatic NSCLC. Location: 1 site in China.\\n- **NCT06248606 (Adagrasib + Stereotactic Radiosurgery for KRAS G12C-mutated NSCLC):** A strong match for your mutation and NSCLC type, targeting brain metastases in advanced cases. It's in phase 2 and recruiting, with potential for patients with similar profiles. Location: 1 site in the United States.\\n- **NCT06936644 (Adagrasib + Pembrolizumab for KRAS G12C-mutated NSCLC):** This one highlights your KRAS G12C mutation and is designed for first-line treatment in advanced or metastatic NSCLC. It's in phase 2 and could be a good option if you haven't started treatment yet. Location: Sites in the United States and potentially others.\\n- **NCT06497556 (Divarasib vs. Other KRAS G12C Inhibitors in NSCLC):** Compares treatments for your mutation in previously untreated advanced NSCLC. It's in phase 3 and recruiting, making it highly relevant for early intervention. Locations: Multiple sites across the United States and internationally.\\n\\n#### **Broader Matches (Related to NSCLC and KRAS Mutations):**\\nThese trials are still connected to your profile but may cover a wider range of KRAS mutations or stages, with some targeting NSCLC in general.\\n- **NCT06917079 (BBO-11818 for KRAS Mutant Cancers):** Involves KRAS G12C and other mutations in advanced NSCLC. It's in phase 1 and recruiting, with a focus on combination therapies that could align with your profile. Locations: Several sites in the United States.\\n- **NCT06582771 (Sotorasib for KRAS G12C-mutated NSCLC):** Targets`... 275793 more characters
    },
    response: {
      id: 'bbfba78b-e314-9910-aad4-745aaa3c74d6',
      timestamp: 2025-08-05T22:09:23.000Z,
      modelId: 'grok-3-mini',
      headers: [Object],
      messages: [Array]
    },
    providerMetadata: { xai: [Object] },
    experimental_providerMetadata: { xai: [Object] },
    isContinued: false
  }
]
Messages:  [
  {
    role: 'assistant',
    content: [ [Object], [Object], [Object] ],
    id: 'msg-niOccRetn8Wp5yy492svcLMI'
  },
  {
    role: 'tool',
    id: 'msg-INIYG91CpoTlKEU5LlpqbyQR',
    content: [ [Object] ]
  },
  {
    role: 'assistant',
    content: [ [Object], [Object] ],
    id: 'msg-UOTD3zeaSky41UmXxcLP7hoE'
  }
]
Response Body:  undefined
Provider metadata:  {
  xai: {
    reasoningTokens: 464,
    acceptedPredictionTokens: 0,
    rejectedPredictionTokens: 0,
    cachedPromptTokens: 3958
  }
}
Sources:  []
Usage:  { promptTokens: 69432, completionTokens: 1171, totalTokens: 70603 }
DB Query: 
      select b.oid, b.typarray
      from pg_catalog.pg_type a
      left join pg_catalog.pg_type b
DB Query: select "id", "userId", "title", "created_at", "updated_at", "visibility" from "chat" where "chat"."i
DB Query: insert into "message" ("id", "chat_id", "role", "parts", "attachments", "created_at") values ($1, $2
--------------------------------
Total request processing time: 60.87 seconds
--------------------------------
 POST /api/search 200 in 60892ms
Pathname:  /search/2cf55642-fd17-41fe-871c-ee84caaccc37
[
  {
    role: 'user',
    content: 'Can you list the trials based on a proximity to chicago?'
  },
  {
    role: 'assistant',
    content: "I see you're looking to refine your trial search based on proximity to Chicago‚Äî that's a smart way to focus on options closer to home. I'll update the search using your health profile and add the location filter for Chicago to find trials within a reasonable distance. This will help prioritize results that are more accessible for you.\n" +
      '\n' +
      'Let me run a new search with these parameters.\n' +
      '\n' +
      "I appreciate your interest in narrowing down those clinical trials to options closer to Chicago‚Äîit's helpful to focus on what's accessible for you. Based on your health profile, which includes a diagnosis of non-small cell lung cancer (NSCLC) with a KRAS G12C mutation, I ran a refined search prioritizing trials near Chicago, Illinois. This ensures the results are tailored to your situation, highlighting studies that target KRAS G12C mutations for potentially better matches.\n" +
      '\n' +
      "From the search, I found 10 relevant trials, with several having sites in or around the Chicago area. These trials are for advanced NSCLC and often involve treatments that align with your KRAS G12C mutation, making them particularly relevant. I'll summarize the top ones below, grouping them by proximity and relevance. Remember, your profile doesn't specify the exact disease stage, so I've focused on matches based on your cancer type and mutation; updating your profile could refine this further.\n" +
      '\n' +
      '### Key Trial Highlights:\n' +
      "Here's a breakdown of the trials, prioritizing those with Chicago sites or nearby locations. I've noted why each might match your profile (e.g., KRAS G12C targeting) and included key details like phase, status, and locations.\n" +
      '\n' +
      '#### **Trials with Sites in Chicago (Direct Matches for Your KRAS G12C Mutation):**\n' +
      'These are the most convenient options, as they include sites right in Chicago. They specifically target KRAS G12C mutations, which aligns with your profile.\n' +
      "- **NCT05920356 (Phase 3 Study of Sotorasib with Chemotherapy):** This trial evaluates sotorasib (a KRAS G12C inhibitor) combined with chemotherapy for advanced NSCLC. It's recruiting and matches your mutation by focusing on KRAS G12C-positive cases. **Location: University of Illinois Chicago (Chicago, IL)** and other sites.\n" +
      "- **NCT06244771 (Phase 1/2 Study of FMC-376):** Focuses on KRAS G12C-mutated solid tumors, including NSCLC, testing a targeted inhibitor. It's in phase 1/2 and recruiting, making it relevant for your mutation profile. **Location: Not directly in Chicago, but nearby sites in the US (e.g., Illinois area).**\n" +
      '\n' +
      '#### **Trials Near Chicago (Broader Matches for NSCLC and KRAS Mutations):**\n' +
      'These have sites in nearby states or regions, potentially within a reasonable distance from Chicago. They still relate to your KRAS G12C mutation but may cover a wider range of NSCLC treatments.\n' +
      "- **NCT05609578 (Phase 2 Study of Adagrasib with Pembrolizumab):** Targets KRAS G12C in advanced NSCLC, combining it with immunotherapy. It's recruiting and a strong fit for your mutation. **Location: Sites in Illinois and surrounding areas (e.g., Chicago region).**\n" +
      "- **NCT06497556 (Phase 3 Study of Divarasib):** Compares KRAS G12C inhibitors for previously treated NSCLC, which could align with your profile if you've had prior therapies. Recruiting now. **Location: Multiple US sites, including nearby Illinois locations.**\n" +
      '- **NCT06248606 (Phase 2 Study of Adagrasib with Radiosurgery):** Specifically for KRAS G12C-mutated NSCLC with brain metastases, offering targeted treatment options. **Location: US sites, potentially accessible from Chicago.**\n' +
      '- **NCT05074810 (Phase 1/2 Study of Avutometinib with Sotorasib):** Focuses on KRAS G12C inhibitors in NSCLC, with combinations that could match your mutation. **Location: Sites in nearby states like Massachusetts and Ohio.**\n' +
      "- **NCT04613596 (Phase 2/3 Study of Adagrasib with Pembrolizumab):** This one highlights KRAS G12C in untreated advanced NSCLC, making it relevant if you're exploring first-line options. **Location: US-wide, with sites in the Midwest region.**\n" +
      '- **NCT04303780 (Phase 3 Study of Sotorasib vs. Docetaxel):** Compares sotorasib (targeting KRAS G12C) to standard chemotherapy for previously treated NSCLC. **Location: Various US sites, including those near Chicago.**\n' +
      '- **NCT06345729 (Phase 1/2 Study of FMC-376):** For KRAS G12C-mutated solid tumors, including NSCLC, with a focus on advanced cases. **Location: US sites in the region.**\n' +
      '- **NCT05074810 (Phase 1/2 Study as above ‚Äì already mentioned, but confirming proximity).**\n' +
      '\n' +
      'These trials are mostly in phases 1-3, actively recruiting, and emphasize KRAS G12C inhibitors, which directly tie into your profile. Locations vary, but the ones in Chicago or nearby could make participation more feasible‚Äîalways check with the trial team for exact site details.\n' +
      '\n' +
      "If you'd like more specifics on any trial (like eligibility, contact info, or a map of the sites), just let me know the NCT ID. For example, I can pull up details for NCT05920356 or help refine the search further. Remember, this information is for educational purposes only‚Äîplease discuss these options with your healthcare provider to determine the best next steps. I'm here to support you! üòä"
  }
]
 POST /search/2cf55642-fd17-41fe-871c-ee84caaccc37 200 in 1491ms
Pathname:  /search/2cf55642-fd17-41fe-871c-ee84caaccc37
DB Query: 
      select b.oid, b.typarray
      from pg_catalog.pg_type a
      left join pg_catalog.pg_type b
DB Query: update "chat" set "visibility" = $1 where "chat"."id" = $2
 POST /search/2cf55642-fd17-41fe-871c-ee84caaccc37 200 in 331ms
Pathname:  /search/2cf55642-fd17-41fe-871c-ee84caaccc37
DB Query: select "id", "userId", "title", "created_at", "updated_at", "visibility" from "chat" where "chat"."u
 POST /search/2cf55642-fd17-41fe-871c-ee84caaccc37 200 in 82ms